SEPRAGEN CORP
10QSB, 1998-11-20
TOTALIZING FLUID METERS & COUNTING DEVICES
Previous: POLK AUDIO INC, DEF 14A, 1998-11-20
Next: GABELLI EQUITY TRUST INC, N-30B-2, 1998-11-20




                                UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C.  20549

                                FORM  10-QSB
  (Mark One)

  [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES  
      EXCHANGE ACT OF 1934
                 For the quarterly period ended:   September 30, 1998

  [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934
                           For the transition period from       to      

                                Commission file number:    0-25726

                            SEPRAGEN CORPORATION
  (Exact name of small business issuer as specified in its charter)

       California                                   68-0073366
  (State or other jurisdiction of              (I.R.S. Employer
  incorporation or organization)               Identification No.)

              30689 Huntwood Avenue, Hayward, California  94544
                  (Address of principal executive offices)

  (Issuer's telephone number (including area code):  (510) 476-0650)

  (Former name, former address and former fiscal year if changed since
  last report:

  Check whether the issuer (1) has filed all reports required to be filed
  by Section 13 or 15(d) of the Exchange Act during the past 12 months (or
  for such shorter period that the issuer was required to file such
  reports), and (2) has been subject to such filing requirements for the
  past 90 days.    Yes  X    No 

  State the number of shares outstanding of each of the registrant's
  classes of Common equity, as of the latest practicable date:
                                                         November 13,1998
                                Class A Common Stock          2,155,254
                                Class B Common Stock            701,177
                                Class E Common Stock          1,209,894

  THIS REPORT INCLUDES A TOTAL OF 60 PAGES. THE INDEX TO EXHIBITS IS ON
  PAGE 14.
<PAGE>
  PART I  -  FINANCIAL INFORMATION
  Item  1.  -  Financial Statements

                            SEPRAGEN CORPORATION
                           CONDENSED BALANCE SHEET
                                   ASSETS
                                                     September 
                                                      30, 1998 
      Current Assets:
           Cash and cash equivalents.              $   206,197 
           Accounts receivable, less allowance
             for doubtful accounts of $12,000 as
             of  September 30, 1998                    180,799 
           Inventories                                 231,355 
           Prepaid expenses and other.                  39,509 
             Total current assets.                     657,860 
           Furniture and equipment, net                198,157 
           Intangible assets                           101,432 
                                                       957,449 

               LIABILITIES AND DEFICIT IN SHAREHOLDERS' EQUITY

      Current Liabilities:
           Accounts payable                            827,895 
           Bridge Loans, net                           522,800 
           Customer deposits                            75,800 
           Notes Payable, including $280,000 from
             shareholders                              380,000 
           Accrued payroll and benefits                122,283 
           Accrued liabilities                          66,487 
           Interest payable                             38,327 
             Total current liabilities               2,033,592 
      Commitments
         Class E common stock, no par value
           - 1,600,000 shares authorized;
           1,209,894 shares issued and
           outstanding at September 30,
           1998, redeemable at $.01 per share                0 
      Deficit in Shareholders' equity:
          Preferred stock, no par value -
            5,000,000 shares authorized; and
            175,439 convertible, preferred
            issued and outstanding                     500,000 
          Class A common stock, no par value
            -20,000,000 shares authorized;
            2,155,254 shares issued and
            outstanding                              8,848,075 
          Class B common stock, no par value -
            2,600,000 shares authorized; 701,177
            shares issued and outstanding            4,065,618 
           Additional paid in capital                  202,220 
           Accumulated deficit                     (14,692,056)
           Total deficit in shareholders' equity    (1,076,143)
                                                       957,449 

  The accompanying notes are an integral part of these condensed financial
  statements.

                                   Page 2

<PAGE>
                            SEPRAGEN CORPORATION

                     CONDENSED STATEMENTS OF OPERATIONS

                                     Three Months              Nine Months
                               Ended September 30       Ended September 30
                                 1998       1997        1998         1997 
   Revenues:
     Net Sales               $356,395   $188,264    1,200,199     731,977 
   Costs and expenses:
     Cost of goods sold       139,564    112,317      649,391     412,274 
   Selling, general and  
     administrative           352,014    311,791      957,530   1,115,059 
   Research and development   172,759    157,881      577,283     669,821 
   Total costs and expenses   664,337    581,989    2,184,204   2,197,154 
                                                 
   Loss from operations      (307,942)  (393,725)   (984,005)  (1,465,177)

   Other income                     --    32,804           --      72,804 
   Interest income,
     (expense) net            (68,669)        25    (177,951)       1,018 

   Net loss                  (376,611)  (360,896) (1,161,956)  (1,391,355)

   Net loss per common
     share,  basic and                                                    
     diluted                    $(.13)     $(.13)      $(.41)       $(.49)
   Weighted average shares   
     outstanding            2,856,431  2,856,431   2,856,431    2,856,431



  The accompanying notes are an integral part of these condensed financial
  statements.


                                   Page 3
<PAGE>
                            SEPRAGEN CORPORATION
                     CONDENSED STATEMENTS OF CASH FLOWS

                                        Nine Months Ended September 30,
                                                    1998           1997 
    Cash flows from operating
    activities:                                                         
         Net Loss                            $(1,161,956)   $(1,391,355)
         Adjustments to reconcile net
           loss to net cash used in
           operating activities:
           Depreciation and
             Amortization                        177,057        102,036 
           Changes in assets and
             liabilities:
              Accounts receivable.               390,069         54,679 
              Inventories                         87,505         23,789 
              Prepaid expenses and
                other                            (22,975)         2,131 
              Accounts payable                   191,641        453,835 
              Accrued liabilities.               (26,233)       (25,704)
              Accrued payroll and                (22,856)         6,180 
                benefits.
              Interest payable                   (16,522)             0 
              Customer deposits                 (234,681)       285,709 
    Net cash used in operating
      activities                                (638,951)      (488,700)
    Cash flows from financing  
      activities:
        Proceeds from issuance of
          preferred stock                        500,000              0 
        Proceeds from notes  payable
          to shareholders                        155,000        125,000 
        Proceeds from issuance of
          notes payable                                0        100,000 
        Net proceeds from bridge
          notes payable                          115,700        207,000 
        Proceeds from issuance of
          convertible secured
          promissory Note, net                   540,000              0 
        Retirement of bridge debt               (510,000)             0 
    Net cash provided by financing                                      
       activities                                800,700        432,000 
    Net increase (decrease) in cash              161,749        (56,700)
    Cash and cash equivalents at the
      beginning of the period                     44,448        217,057 
    Cash and cash equivalents at the
      end of the period.                      $  206,197     $  160,357 

  The accompanying notes are an integral part of these condensed financial
  statements.

                                   Page 4
<PAGE>
                            SEPRAGEN CORPORATION

                   NOTES TO CONDENSED FINANCIAL STATEMENTS
                 NINE MONTH PERIOD ENDED SEPTEMBER 30, 1998

  Note 1 - Basis of Presentation

       These condensed financial statements have been presented on a going
  concern basis.  Sepragen, (the "Company") has incurred recurring losses
  and cash flow deficiencies from operations that raise substantial doubt
  about its ability to continue as a going concern.  As of September 30,
  1998, the Company had an accumulated deficit of $14,692,056.

       The Company will be required to conduct significant research,
  development and testing activities which, together with expenses to be
  incurred for manufacturing, the establishment of a large marketing and
  distribution presence and other general and administrative expenses, are
  expected to result in operating losses for the foreseeable future. 
  Accordingly, there can be no assurance that the Company will ever
  achieve profitable operations.  The Company will have to obtain
  additional financing to support its operating needs beyond December
  31,1998.  The Company is currently pursuing alternative funding sources
  to meet its cash flow needs, including private debt and equity
  financing.  Management intends to use such funding to further its
  marketing efforts and expand sales.  It is uncertain, however, whether
  the Company will be  successful in such pursuits.  No adjustments have
  been made to the accompanying condensed financial statements for this
  uncertainty.

  Note 2 - Interim Financial Reporting

       The accompanying unaudited interim financial statements have been
  prepared pursuant to the rules and regulations for reporting on Form 10-
  QSB.  Accordingly, certain information and footnotes required by
  generally accepted accounting principles have been condensed or omitted. 
  These interim statements should be read in conjunction with the
  financial statements and the notes thereto, included in the Company's
  Annual Report on Form 10-KSB for the year ended December 31, 1997.

  Note 3 - Net Loss Per Share.

       The Company has adopted Statement of Financial Accounting Standards
  (SFAS) No. 128, Earning per Share for all periods presented.  The
  adoption of SFAS No. 128 had no impact on previously reported loss per
  share for the three months ended September 30, 1997.  In accordance with
  SFAS No. 128, primary earnings (loss) per share has been replaced with
  basic earnings (loss) per share, and fully diluted earnings (loss) per
  share has been replaced with diluted earnings (loss) per share which
  includes potentially dilutive securities such as outstanding options and
  convertible securities, using the treasury stock method.  The assumed
  exercise of options and warrants and assumed conversion of convertible
  securities have not been included in the calculation of diluted loss per
  share as the effect would be anti-dilutive.

  Note 4 - The "Year 2000 Problem", dates following December 31, 1999 and
  beyond:

       Many existing computer systems and applications, and other devices,
  use only two digits to identify a year in the date field, without
  considering the impact of the upcoming change in the century. Such
  systems and applications could fail or create erroneous results unless
  corrected. The Company relies on its internal financial systems and
  external systems of business enterprises such as customers, suppliers,
  creditors, and financial organizations both domestically and globally,
  directly and indirectly for accurate exchange of data.  The Company has
  evaluated such systems and believes the cost of addressing the "Year
  2000 Problem" will not have a material adverse affect on the result of
  operations of financial position of the Company. However, although the
  internal systems of the Company are not materially affected by the Year
  2000 issue, the Company could be affected through disruption in the
  operation of the enterprises with which the Company interacts.

  Note 5 - Notes Payable

       Between May 1997 and August 1998, the Company borrowed an aggregate
  of $380,000 of which 280,000 are from shareholders of the Company,
  payable with interest at 9.5% per annum due on March 1, 1999 and 100,000
  from an unrelated party payable with interest at 9.5% per annum due on
  December 31, 1998.  The repayment of these notes is subordinate to the
  claims of the note described in Note 6.  


  Note 6 -  Bridge Notes Payable

       In August 1998, the Company completed a debt-refinancing
  transaction whereby the Company borrowed $550,000 from Mr. K. Charles
  Janac pursuant to a Convertible Secured Promissory Note issued by the
  Company (the "Note") in the principal amount of $550,000 and bearing
  interest at the rate of 9.75% per annum.  The Note is convertible into
  shares of Class A Common Stock at the option of Mr. Janac at any time
  before December 15, 1998 by converting the principal balance and any
  unpaid interest due under the Note into Class A Common Stock at the rate
  of $0.468 per share.  In addition, as further consideration for the loan
  of funds to the Company, the Company issued to Mr. Janac a warrant,
  exercisable at any time on or before August 18, 2003, to purchase up to
  234,667 shares of Class A Common Stock at $.468 per share (the
  "Warrants").  The total number of shares of Class A Common Stock
  issuable upon conversion of the Note or exercise of the Warrants are
  subject to adjustment in the event of recapitalization, stock dividends,
  or similar events.  As security for the Note, the Company entered into a
  Security Agreement granting Mr. Janac a first priority security interest
  in the property, tangible and intangible, of the Company, as well as a
  Patent and Trademark Mortgage granting Mr. Janac a security interest in
  all the patents and trademarks of the Company.

       All principal and accrued interest under the Note is due and
  payable on or before December 15, 1998.

       The business address of Mr. Janac is 651 River Oaks Parkway, San
  Jose, CA 95134.

       The Company used the funds loaned by Mr. Janac to retire
  $532,242.47 of existing debt incurred by the Company in connection with
  a certain bridge financing originally undertaken by the Company in
  October of 1997, to pay legal fees and costs of the transaction, and
  approximately $7,000 was utilized for working capital.

       The fair value of the warrants (calculated using the Black Scholes
  Pricing Model) is $91,520 and is being amortized over the remaining term
  of the loan, 4 months.  Amortization for the three and nine months ended
  September 30, 1998 was $34,320. In addition, the Company secured payment
  extensions on the remaining $30,000 in bridge loans through March 31,
  1999.


  Note 7 - Convertible Preferred Stock

       On September 1, 1998, the Company sold 175,439 Shares of Series A
  Preferred Stock.

       All of the shares of Series A Preferred Stock were sold to Anchor
  Products Limited of Hamilton, New Zealand ("Anchor").  The acquisition
  of Series A Preferred Stock by Anchor was consummated in connection with
  the execution of a Commercial License Agreement between the Company and
  Anchor, whereby the Company licensed Anchor a technology that isolates
  proteins from whey, a low value cheese by-product.  The shares of Series
  A Preferred Stock were sold for cash in the aggregate amount of $500,000
  ($2.85 per share).  There were no underwriting discounts or commissions
  paid in connection with the transaction.

       The shares of Series A Preferred Stock were sold pursuant to
  exemptions from registration under Section 4(2) and Regulation S under
  the Securities Act of 1933, in a transaction that was not publicly
  offered.  Anchor is a New Zealand corporation.

       The Company's Series A Preferred Stock provides for both a 7%
  dividend and liquidation preferences.  The dividend is payable from time
  to time at the election of the Board of Directors of the Company subject
  to the Company retaining sufficient earnings and profits.  The Preferred
  Stock is also convertible on or before September 30, 2000 into Class A
  Common Stock, at the conversion rate of $2.86 per share.  On any
  voluntary or involuntary liquidation, dissolution or winding-up of the
  Company, the holders of Series A Preferred Shares shall receive, out of
  the assets of the Company, the sum of $2.86 per Series A Preferred
  Share, plus an amount equal to any dividends accrued and unpaid on those
  Series A Preferred Shares, before any payment shall be made or any
  assets distributed to the holders of Common Stock.  The Series A
  Preferred Shares shall be redeemable at the option of the holders of the
  Series A Preferred Shares commencing September 30, 2003 and expiring
  December 31, 2008, at the cash price of $2.86 per share, plus any
  accrued and unpaid dividends on the Series A Preferred Shares which are
  redeemed.  In addition, each share of Series A Preferred Stock shall be
  automatically converted into one (1) share of Class A Common Stock, if
  not previously redeemed, on January 1, 2009, or at any time the closing
  bid price per share of the Company's Class A Common Stock shall average
  at least $3.86 per share over ninety (90) consecutive trading days prior
  to January 1, 2004.  The conversion ratio for the Series A Preferred
  Stock shall be adjusted in the event of recapitalization, stock
  dividend, or any similar event effecting the Class A Common Stock. 

       Anchor may require the Company to immediately redeem the preferred
  shares in the event of certain covenant breaches of the license
  agreement by the Company. The Company is currently in compliance with
  all such covenants and does not anticipate any breaches in the future.

  Item 2 .  Management's Discussion and Analysis.

  First nine months of 1998 compared to first nine months of 1997.

       Net sales increased by $468,000 or 64% from $732,000 in the first
  nine months of 1997 to $ 1,200,000 for the comparable period in 1998. 
  The increase in sales is due to the increase of sales of its core
  products, Radial Flow Chromatography (RFC) equipment and a $200,000
  license fee for the Sepralac process received from Anchor products of
  New Zealand.

       Gross Margin increased by $231,000 or 72% from $320,000 in the
  first nine months  of 1997 to $551,000 in the first nine months of 1998. 
  The increase in gross margin is primarily due to a higher production
  volume and revenue generated from license fee that does not have cost of
  goods associated with it. As a percentage of sales, gross margin
  increased slightly from 44% in the first three quarters of  1997 to 46% 
  for the comparable period in 1998, primarily due to the license fee
  income which more than offset the lower margins realized from sales of
  core products. 

       Selling, general and administrative expenses decreased by $158,000
  from $1,115,000 in the first nine months of 1997 to $957,530 in the
  first nine months of 1998. The decrease was primarily due to continued
  belt tightening measures adopted in mid 1997 in administrative expenses
  coupled with a reduction in head count in sales and marketing, scaling
  back of advertising and promotion and travel expenses partially offset
  by $49,000 write-off of expenses related to the Company's financing
  activities.

       Research and development expenses decreased by $93,000 from
  $670,000 in the first nine months of 1997 to $577,000 in the first nine
  months of 1998.  The decrease was mainly due to the reduction in the
  cost of software development for the QuantaSep product.

       Interest and other expense increased by $179,000 in the first nine
  months of 1998 compared to the first nine months of 1997 due to
  amortization of $70,000 of issuance cost, amortization of the fair value
  of warrants issued of $34,000 and $75,000 interest expense related to
  the bridge loans and notes payable. 


  Third quarter 1998 compared to third quarter 1997.

       Net sales increased by $168,000 from $188,000 in the third quarter
  of 1997 to $356,000 in the third quarter of 1998. The increase in sales
  is due to $200,000 license fee received for the Sepralac(R) Process
  partially offset by small decrease in sales of the core products, Radial
  Flow Chromatography (RFC) equipment.

       Gross margin increased by $141,000 or 186% from $76,000 in the
  third quarter of 1997 to $217,000 in the third quarter of 1998, and as a
  percent of sales, increased by 21% from 40% to 61%.  The higher margin
  was attributable to the Sepralac license fee received  in the third of
  quarter of 1998, which more than offset the lower margins realized on
  sales of core products.

       Selling, general and administrative expense increased by $40,000 or
  13%. The increase is due to a write-off of $49,000  legal, printing,
  commission related to a private placement financing.

       Research and development expenses increased by $15,000 or 9% from
  $158,000 in the third quarter of 1997 to $173,000 in the third quarter
  of 1998. This increase was  due  to a one time severance pay related to
  the reorganization of the department. 

  Inflation.

       The Company believes that the impact of inflation on its operations
  since its inception has not been material.

  Liquidity and Capital Resources:

       The Company use of cash for operations was $639,000 and $488,000
  during the nine months ended September 30, 1998 and 1997, respectively.
  Cash used in operations in the first nine months  of 1998 was the result
  of net loss incurred for the nine six months  of $1,162,000, offset by
  net non-cash expense of $177,000,  the net change in operating assets
  and liabilities resulting in source of cash of $346,000. Cash used in
  the first nine months  of 1997 was the result of  net loss incurred for
  the nine months of $1,391,000, offset by net non-cash expenses of
  $102,000, and the net change in operating assets and liabilities
  resulting in source of cash of  $801,000.

       Financing activities provided cash of $800,700 during the first
  nine months of 1998. The cash provided resulted from the subscription
  proceeds for preferred stock of $500,000 and issuance of notes payable
  of $300,700.

       At September 30, 1998 the Company had cash and cash equivalents of
  $206,200 as compared with $44,400 on December 31, 1997.  At September
  30, 1998, the Company had working capital deficit of $1,375,700, as
  compared to working capital deficit of  $902,000 at December 31, 1997. 
  The decrease in cash in the first nine months of 1998 is a result of the
  aforementioned increase or decrease in cash from operating and financing
  activities noted above. The decrease in working capital for the first
  nine months is primarily a result of the net loss incurred offset by
  non-cash charges.  

       This negative cash out flow from operations must be reversed and
  working capital increased significantly in order for the Company to fund
  its existing activities and to extend the use of its technology to new
  applications in the food and dairy and juice industries, and to attract
  the interest of strategic partners in one or more of these markets.

       Based on the Company's current operating plan, the Company believes
  that it will only be able to fund the Company's operations through
  December 31, 1998.  Accordingly, the Company will have to either turn
  profitable or obtain additional funds to support its operations.  The
  Company is currently pursuing several avenues including increasing
  revenues and reducing costs in order to turn profitable, secure funds
  through additional strategic partnerships and secure either debt or
  equity financing.

       Following this strategy, on August 25, 1998, the Company announced
  the signing of a license agreement with Anchor Products. Under this
  agreement, Anchor Products will have exclusive manufacturing rights to
  the Sepralac(R) process in Australia and New Zealand and non-exclusive
  worldwide marketing rights to products produced by the Sepralac(R)
  Process. In return, the Company has received $700,000 out of  a total of
  about $1 million from Anchor Products, comprised of a license fee of
  $200,000 and an equity investment of $500,000 for the purchase of 
  175,439 redeemable, cumulative, preferred stock at $2.85 per share. The
  preferred stock is convertible into common stock (on share for share
  basis) at any time within the next 2 years and extendible for a further
  1 year at the Company's option. 

       On October 15, 1998, the Company announced a licensing agreement
  for the Sepralac(R) Process with Carberry Milk Products of Ballineen,
  County Cork, Ireland. Under the agreement, Carberry will have
  manufacturing and marketing rights to certain products produced from the
  Sepralac(R) Process. In return, the Company will receive a license fee
  of $350,000 payable $200,000 before January 1, 1999 and the balance over
  the term of the agreement.  Further, Carberry  agreed to an initial
  purchase of equipment worth approximately  $100,000.  

       The evaluation agreement  to commercialize the Sepralac(R) Process 
  between Sepragen Corporation and California Gold Dairy Products of
  Petaluma, California by mutual agreement  was terminated on September 8,
  1998. 
       A technical evaluation  agreement  for the Debitt(R) Process, a
  debittering and deacidification process using Sepragen Corporation's 
  RFC(R)  Column, has been signed with Tropicana products.

       The Company currently has no credit facility with a bank or other
  financial institution.  Further, the Company's stock is traded over-the-
  counter and as such there is limited liquidity in the Company's stock
  which makes financing difficult.

       The Company is seeking to enter into strategic alliances with
  corporate partners in the industries comprising its primary target
  markets (biopharmaceutical, food, dairy and juice).  The Company's
  ability to further develop and market its Sepralaca Process for whey
  separation and other potential food and juice products and processes
  will be substantially dependent upon its ability to negotiate
  partnerships, joint ventures or alliances with established companies in
  each market.  In particular, the Company will be reliant on such joint
  venture partners or allied companies for both market introduction,
  operational assistance and financial assistance.  The Company believes
  that development, manufacturing and market introduction of products in
  these industries, will cost millions of dollars and require operational
  capabilities in excess of those currently available to the Company.  No
  assurance can be given, however, that the terms of any additional
  alliances will be successfully negotiated  or that such alliance will be
  successful in generating the revenue required to make the Company
  profitable. 

  Cautionary Statement for Purposes of the "Safe Harbor" Provisions of the
  Private Securities Litigation Reform Act of 1995.

       This report contains or incorporates by reference forward-looking
  statements within the meaning of the Private Securities Litigation
  Reform Act of 1995.  Where any such forward-looking statement includes a
  statement of the assumptions or bases underlying such forward-looking
  statement, the Company cautions that, while such assumptions or bases
  are believed to be reasonable and are made in good faith, assumed facts
  or bases almost  always vary from the actual results, and the
  differences between assumed facts or bases and actual results can be
  material, depending upon the circumstances.  Where, in any forward-
  looking statement, the Company or its management expresses an
  expectation or belief as to future results, such expectation or belief
  is expressed in good faith and is believed to have a reasonable basis,
  but there can be no assurance that the statement of expectation or
  belief will result or be achieved or accomplished.  The words "believe,"
  "estimate," "anticipate," and similar expressions may identify forward-
  looking statements.

       Taking into account the foregoing, the following are identified as
  some but not all of the important factors that could cause actual
  results to differ materially from those expressed in any forward-looking
  statement made by, or on behalf of the Company:

       Inability to Secure Additional Capital.  The Company has incurred
  operating losses each fiscal year since its inception.  The Company must
  secure additional financing through either the sale of additional
  securities or debt financing to continue operations past January 1,
  1999.  Although the Company is attempting to secure such financing,
  there can be no assurance that such financing will be available to the
  Company on reasonable terms.  The Company has been delisted from the
  Nasdaq SmallCap Market and the Pacific Stock Exchange.  See Item 2
  "Management's Discussion and Analysis-Liquidity and Capital Resources."

       Competition.  In both its biopharmaceutical industry market and in
  the market for its process systems for food, beverage, dairy and
  environmental industries, the Company faces intense competition from
  better capitalized competitors.

       Dependence on Joint Ventures and Strategic Partnerships.  The
  Company's entry into the food, dairy and beverage market for its process
  systems will be substantially dependent upon its ability to enter into
  strategic partnerships, joint ventures or similar collaborative alliance
  with established companies in each market.  As of the date of this
  report, two licensing agreements have been signed but  there can be no
  assurance that the terms of any such alliance will produce profits for
  the Company nor can there be assurance that additional joint ventures or
  alliances will be signed.

       Management Reorganization: Since September 5, 1998, Dr. Q.R.
  Miranda, Vice President of Research and Development has not been
  employed by Sepragen Corporation. 

                                   PART II
                              OTHER INFORMATION

  Item 1.   Legal Proceedings
                 Not Applicable

  Item 2.   Changes in Securities
            See footnotes 6 and 7 of the financial statements.

  Item 3.   Defaults Upon Senior Securities
                 Not Applicable

  Item 4.   Submission of Matters to a vote of Security Holders
                 Not Applicable

  Item 5.   Other Information
                 Not Applicable

  Item 6.   Exhibits and Reports on Form 8-K  

       (a)  Exhibits

            4.8     Warrant Agreement with Charles Janac

            10.9    Convertible Secured Promissory Note issued by the
                    Company to Charles Janac

            10.10   Security Agreement with Charles Janac

            10.11   Patent and Trademark Mortgage

       (b)  Reports on Form 8-K

            Form 8-K, dated August 14, 1998, Items 5, 7 and 9.

                                 SIGNATURES

       In accordance with the requirements of the Exchange Act, the
  Registrant caused this report to be signed on its behalf by the
  undersigned thereunto duly authorized.

                                SEPRAGEN CORPORATION

  DATE: November 19, 1998       By: /s/Vinit Saxena
                                    Vinit Saxena
                                    Chief Executive Officer, President and
                                    Principal Financial and Chief
                                    Accounting Officer
<PAGE>
                              INDEX TO EXHIBITS


                                                        Sequential Page No.

  4.8       Warrant Agreement with Charles Janac              14

  10.9      Convertible Secured Promissory Note issued 
            by the Company to Charles Janac                   24

  10.10     Security Agreement with Charles Janac             29

  10.11     Patent and Trademark Mortgage                     45

                                EXHIBIT 4.8

  THE SECURITY EVIDENCED BY THIS WARRANT OR THE SECURITIES TO BE PURCHASED
  UNDER THIS WARRANT, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
  1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR
  HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER
  SUCH ACT COVERING SUCH SECURITIES. THE SALE IS MADE IN ACCORDANCE WITH
  RULE 144 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL
  FOR THE HOLDER OF THESE SECURITIES REASONABLY SATISFACTORY TO THE
  COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION
  IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENT
  UNDER SUCH ACT.

            VOID AFTER 5 P.M., CALIFORNIA TIME ON AUGUST 18, 2003


                             WARRANT TO PURCHASE
                            CLASS A COMMON STOCK

       SEPRAGEN CORPORATION, a California corporation (the "Company"),
  hereby certifies that K. CHARLES JANAC or his registered assign(s)
  (collectively referred to as the "Holder") is entitled, subject to the
  terms set forth below, to purchase from the Company Two Hundred Thirty
  Four Thousand Six Hundred and Sixty Seven (234,667) fully paid and
  nonassessable shares of the Class A Common Stock of the Company (the
  "Shares") at the purchase price of $0.46875 per share (the "Purchase
  Price"). Both the Purchase Price and such number of Shares are subject
  to adjustments as described below.

       1.   Exercise of Warrant; Reservation of Shares. Subject to the
  restrictions herein, this warrant may be exercised in whole or in part
  by the Holder at any time before 5 p.m., California local time, on
  August 18, 2003 by the surrender of this Warrant, together with the
  Notice of Exercise attached hereto as Attachment 1, duly completed and
  executed, at the principal office of the Company, accompanied by payment
  in cash or by check in full with respect to the Shares being purchased.
  This Warrant shall be deemed to have been exercised immediately prior to
  the close of business on the date of its surrender for exercise as
  provided above. The Company shall at all times after the date of this
  Warrant and until expiration of this Warrant reserve for issuance and
  delivery upon issuance of this Warrant the number of Shares of Common
  Stock required for exercise of this Warrant.

       2.   Delivery of Stock Certificates, Etc. on Exercise. As soon as
  practicable after the exercise of this Warrant, and in any event within
  thirty (30) days thereafter, the Company at its expense (including the
  payment by it of any applicable issue taxes) will cause to be issued in
  the name of, and delivered to, the Holder hereof, or as such Holder
  (upon payment by such Holder of any applicable transfer taxes) may
  direct, (i) a certificate or certificates for the number of Shares to
  which such Holder shall be entitled upon such exercise and (ii) if this
  Warrant is not exercised in full, a warrant containing terms identical
  to herein, provided the number of Shares subject to this Warrant shall
  be reduced by the number of Shares exercised by delivery of the Notice
  of Exercise pursuant to Section 1.

       3.   Adjustment of Exercise Price and Number of Shares. The
  Exercise Price and the total number of Warrant Shares shall be subject
  to adjustment from time to time upon the occurrence of certain events
  described in this Section 3. Upon each adjustment of the Exercise Price,
  the Holder of this Warrant shall thereafter be entitled to purchase, at
  the Exercise Price resulting from such adjustment, the number of shares
  obtained by multiplying the Exercise Price in effect immediately prior
  to such adjustment by the number of shares purchasable pursuant hereto
  immediately prior to such adjustment, and dividing the product thereof
  by the Exercise Price resulting from such adjustment.

            3.1  Subdivision or Combination of Stock. In case the Company
  shall at any time subdivide its outstanding shares of any class of
  Common Stock into a greater number of shares, the Exercise Price in
  effect immediately prior to such subdivision shall be proportionately
  reduced and the number of Warrant Shares issuable hereunder
  proportionately increased, and conversely, in case the outstanding
  shares of any class of the Common Stock of the Company shall be combined
  into a smaller number of shares, the Exercise Price in effect
  immediately prior to such combination shall be proportionately increased
  and the number of Warrant Shares issuable hereunder proportionately
  decreased.

            3.2  Reclassification. If any reclassification of the capital
  stock of the Company or any reorganization, consolidation, merger, or
  any sale, lease, license, exchange or other transfer (in one transaction
  or a series of related transactions) of all or substantially all, of the
  business and/or assets of the Company (the "Reclassification Events")
  shall be effected in such a way that holders of any class of Common
  Stock shall be entitled to receive stock, securities, or other assets or
  property, then, as a condition of such Reclassification Event lawful and
  adequate provisions shall be made whereby the Holder hereof shall
  thereafter have the right to purchase and receive (in lieu of the shares
  of Common Stock of the Company immediately theretofore purchasable and
  receivable upon the exercise of the rights represented hereby) such
  shares of stock, securities, or other assets or property as may be
  issued or payable with respect to or in exchange for a number of
  outstanding shares of such Common Stock equal to the number of shares of
  such stock immediately theretofore purchasable and receivable upon the
  exercise of the rights represented hereby. In any Reclassification
  Event, appropriate provision shall be made with respect to the rights
  and interests of the Holder of this Warrant to the end that the
  provisions hereof (including, without limitation, provisions for
  adjustments of the Exercise Price and of the number of Warrant Shares),
  shall thereafter be applicable, as nearly as may be, in relation to any
  shares of stock, securities, or assets thereafter deliverable upon the
  exercise hereof.

            3.3  Adjustments Upon Issuance of Additional Stock. If the
  Company shall issue "Additional Stock" (as defined below) for a
  consideration per share less than the Exercise Price then in effect on
  the date and immediately prior to such issue, then and  in such event,
  such Exercise Price shall be reduced concurrently with such issue, to a
  price equal to the price per share for such Additional Stock.

       For purposes of this subsection "Additional Stock" shall mean all
  common stock issued by the Corporation after the date hereof other than
  common stock issued or issuable at any time (1) upon conversion of any
  preferred stock; (2) upon exercise of options issued to officers,
  directors, and employees of, and consultants to, the Company after the
  date hereof and approved by the Board of Directors pursuant to an
  employee stock option plan; or (3) upon exercise of Warrants outstanding
  on the date hereof (4) after August 18 1999; (5) provided, however, that
  the company shall not be deemed to have issued additional stock until
  after the Company has issued securities with aggregate proceeds to the
  Company of $500,000.

       For the purpose of making any adjustment in the Exercise Price as
  provided above, the consideration received by the Company for any issue
  or sale of Additional Stock will be computed:

                 (a)  to the extent it consists of cash, as the amount of
  cash received by the Company before deduction of any offering expenses
  payable by the Company and any underwriting or similar commissions,
  compensation, or concessions paid or allowed by the Company in
  connection with such issue or sale;

                 (b)  to the extent it consists of property other than
  cash, at the fair market value of that property as determined in good
  faith by the Company s Board of Directors; and

                 (c)  if common stock is issued or sold together with
  other stock or securities or other assets of the Company for a
  consideration which covers both, as the portion of the consideration so
  received that may be reasonably determined in good faith by the Board of
  Directors to be allocable to such common stock.  

       If the Company (1) grants any rights or options to subscribe for,
  purchase, or otherwise acquires common stock, or (2) issues or sells any
  security convertible into common stock, then, in each case, the price
  per share of common stock issuable on the exercise of the rights or
  options or the conversion of the securities will be determined by
  dividing the total amount, if any, received or receivable by the Company
  as consideration for the granting of the rights or options or the issue
  or sale of the convertible securities, plus the minimum aggregate amount
  of additional consideration payable to the Company on exercise or
  conversion of the securities, by the maximum number of shares of common
  stock issuable on the exercise of conversion. Such granting or issue or
  sale will be considered to be an issue or sale for cash of the maximum
  number of shares of common stock issuable on exercise or conversion at
  the price per share determined under this subsection, and the Exercise
  Price will be adjusted as above provided to reflect (on the basis of
  that determination) the issue or sale. No further adjustment of the
  Exercise Price will be made as a result of the actual issuance of common
  stock on the exercise of any such rights or options or the conversion of
  any such convertible securities.

       Upon the redemption or repurchase of any such securities or the
  expiration or termination of the right to convert into, exchange for, or
  exercise with respect to, common stock, the Exercise Price will be
  readjusted to such price as would have been obtained had the adjustment
  made upon their issuance been made upon the basis of the issuance of
  only the number of such securities as were actually converted into,
  exchanged for, or exercised with respect to, common stock. If the
  purchase price or conversion or exchange rate provided for in any such
  security changes at any time, then, upon such change becoming effective,
  the Exercise Price then in effect will be readjusted forthwith to such
  price as would have been obtained had the adjustment made upon the
  issuance of such securities been made upon the basis of (1) the issuance
  of only the number of shares of common stock theretofore actually
  delivered upon the conversion, exchange or exercise of such securities,
  and the total consideration received therefor, and (2) the granting or
  issuance, at the time of such change, of any such securities then still
  outstanding for the consideration, if any, received by the Company
  therefor and to be received on the basis of such changed price or rate.

            3.4  Notice of Adjustment. Upon any adjustment of the Exercise
  Price or any increase or decrease in the number of Warrant Shares, the
  Company shall give written notice thereof, by first class mail postage
  prepaid, addressed to the registered Holder of this Warrant at the
  address of such Holder as shown on the books of the Company. The notice
  shall be prepared and signed by the Company s Chief Financial Officer
  and shall state the Exercise Price resulting from such adjustment and
  the increase or decrease, if any, in the number of shares purchasable at
  such price upon the exercise of this Warrant, setting forth in
  reasonable detail the method of calculation and the facts upon which
  such calculation is based.

       4.   Notices of Record Date, Etc. In the event of any taking by the
  Company of a record of the holders of any class of securities for the
  purpose of determining the holders thereof who are entitled to receive
  any dividend (other than a cash dividend at the same rate as the rate of
  the last cash dividend theretofore paid) or other distribution (the
  "Distribution") the Company will mail or cause to be mailed to the
  Holder of the Warrant a notice specifying the date of any such
  Distribution and stating the amount and character of such Distribution.
  Such notice shall be mailed at least ten (10) days prior to the date
  therein specified.

       5.   Replacement of Warrant. Upon receipt of evidence reasonably
  satisfactory to the Company of the loss, theft, destruction or
  mutilation of this Warrant and, in the case of any such loss, theft or
  destruction, upon delivery of an indemnity agreement reasonably
  satisfactory in form and amount to the Company or, in the case of such
  mutilation, upon surrender and cancellation of this Warrant, the Company
  at its expense will execute and deliver, in lieu thereof, a new warrant
  of like tenor.

       6.   Negotiability, Etc. This Warrant may be transferred in whole
  or in part by the Holder to any person who, in the opinion of counsel
  reasonably satisfactory to the  Company, is a person to whom this
  Warrant or the Shares may be legally transferred without registration
  and without the delivery of a current prospectus under the Securities
  Act of 1933, as amended (the "Act"), as well as applicable State
  Securities laws with respect thereto, and then only against receipt of
  an agreement of such person to comply with the provisions of this
  section with respect to any resale or disposition of such securities
  unless, in the opinion of counsel to the Company, such agreement is not
  required. The terms hereof shall be binding upon the executors,
  administrators, heirs and assigns of the Holder.

       7.   Notices, Etc. All notices and other communication shall be
  mailed by first class mail, postage prepaid, at such address as may have
  been furnished in writing by the receiving party.

       8.   Governing Law Headings. This Warrant is being delivered in the
  State of California and shall be construed and enforced in accordance
  with and governed by the laws of such state. The headings of this
  Warrant are for purposes of reference only, and shall not limit or
  otherwise affect any of the terms hereof.

       9.   Conversion of Warrant.

            9.1  Right to Convert. In addition to, and without limiting
  the other rights of the Holder hereunder, the Holder shall have the
  right (the "Conversion Right") to convert this Warrant or any part
  hereof into Shares at any time and from time to time during the term
  hereof. Upon exercise of the Conversion Right with respect to a
  particular number of Shares (the "Converted Shares"), the Company shall
  deliver to the Holder, without payment by the Holder, or any Purchase
  Price or any cash or other consideration, that number of Shares computed
  using the following formula:

            X = (B-A)/Y

  Where:    X =  The number of Shares to be issued to the Holder.

            Y =  The fair Market Value of one Share as of the Conversion
                 Date. If. the Company's Common Stock is publicly traded
                 at the time of exercise of this Warrant, the Fair Market
                 Value shall be the average closing price of the Company's
                 Common Stock on the five trading days prior to the
                 Conversion Date. If the Company's Common Stock is not
                 publicly traded at the time of exercise of this Warrant,
                 the Fair Market Value of one Share as of the Conversion
                 Date shall be determined in good faith by the Board of
                 Directors of the Company. 

            B =  The Aggregate Fair Market Value (i.e., Fair Market Value
                 x Converted Shares) 

            A =  The Aggregate Purchase Price (i.e., Purchase Price x
                 Converted Shares)

            9.2  Method of Exercise. The Conversion Right may be exercised
  by the Holder by the surrender of this Warrant at the Company's
  principal office, together with a written statement (the "Conversion
  Statement") specifying that the Holder intends to exercise the
  Conversion Right and indicating the number of Shares to be acquired upon
  exercise of the Conversion Right. Such conversion shall be effective
  upon the Company's receipt of this Warrant, together with the Conversion
  Statement, or on such later date as is specified in the Conversion
  Statement (the "Conversion Date"). Certificates for the Shares so
  acquired shall be delivered to the Holder within a reasonable time, not
  exceeding thirty (30) days after the Conversion Date. If applicable, the
  Company shall, upon surrender of this Warrant for cancellation, deliver
  a new Warrant evidencing the rights of the Holder to purchase the
  balance of the Shares which Holder is entitled to purchase hereunder.
  The issuance of Shares upon exercise of this Warrant shall be made
  without charge to the Holder for any issuance tax with respect thereto
  or any other cost incurred by the Company in connection with the
  conversion of this Warrant and the related issuance of Shares.

  Date:               SEPRAGEN CORPORATION
                      By: /s/ Vinit Saxena
                      Its: President


<PAGE>


                                ATTACHMENT I
                             NOTICE OF EXERCISE

  TO:  SEPRAGEN CORPORATION  
       30689 HUNTWOOD AVENUE  
       HAYWARD, CA 94544

       1.   The undersigned hereby elects to acquire          shares of
  Class A Common Stock of SEPRAGEN CORPORATION pursuant to the terms of
  the attached Warrant, by exercise or conversion of           shares and
  tenders herewith payment of the Purchase Price in full, together with
  all applicable transfer taxes, if any.

       2.   Please issue a certificate or certificates representing said
  shares of Series C Preferred Stock in the name of the undersigned or in
  such other name as is specified below:

                 NAME
                 ADDRESS


                                     DATE


                                     (Name of Warrant Holder)

                                     By:

                                     Title:

                                     (Name of purchaser, and title and
                                     signature of authorized person)


                                     Social Security Number or Federal
                                     Employer ID Number:

                               EXHIBIT 10.9

       THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT PURPOSES ONLY AND MAY
  NOT BE TRANSFERRED UNTIL (i) A REGISTRATION STATEMENT UNDER THE
  SECURITIES ACT OF 1933, AS AMENDED THE "ACT" SHALL HAVE BECOME EFFECTIVE
  WITH RESPECT THERETO OR (ii) RECEIPT BY THE ISSUER OF AN OPINION OF
  COUNSEL REASONABLY SATISFACTORY TO THE ISSUER TO THE EFFECT THAT
  REGISTRATION UNDER THE ACT IS NOT REQUIRED IN CONNECTION WITH SUCH
  PROPOSED TRANSFER NOR IS IN VIOLATION OF ANY APPLICABLE STATE SECURITIES
  LAWS. THIS LEGEND SHALL BE ENDORSED UPON ANY NOTE ISSUED IN EXCHANGE FOR
  THIS NOTE.

                            SEPRAGEN CORPORATION

  No. 1                                                            $550,000
  Dated: August 18, 1998

                     CONVERTIBLE SECURED PROMISSORY NOTE

       SEPRAGEN CORPORATION, a California corporation (the "Company"), for
  value received, hereby promises to pay to K. Charles Janac or registered
  assigns (the "Payee") on December 15, 1998 (the "Maturity Date") at the
  offices of the Company, 30689 Huntwood Avenue, Hayward, California
  94544, the principal amount of Five Hundred Fifty Thousand Dollars
  ($550,000), including interest at the rate of nine point seventy-five
  percent (9.75%) per annum accrued through the Maturity Date, in such
  coin or currency of the United States of America as at the time of
  payment shall be legal tender for the payment of public and private
  debts, unless converted earlier into Class A Common Stock of the
  Company.

       This Note is issued pursuant to a Subscription Agreement dated as
  of August 18, 1998 between the Company and the Payee (the "Subscription
  Agreement"), a copy of which agreement is available for inspection at
  the Company's principal office. Notwithstanding any provision to the
  contrary contained herein, this Note is subject and entitled to certain
  terms, conditions, covenants and agreements contained in the Subscrip-
  tion Agreement. Any transferee or transferees of the Note, by their
  acceptance hereof, assume the obligations of the Payee in the Subscrip-
  tion Agreement with respect to the conditions and procedures for
  transfer of the Note. Reference to the Subscription Agreement shall in
  no way impair the absolute and unconditional obligation of the Company
  to pay both principal and interest hereon as provided herein.

       On or before the Maturity Date, the Payee may elect to receive
  payment of the principal amount of this Note or any part thereof and
  accrued interest (the "Conversion Amount") in the form of Class A Common
  Stock (the "Equity Conversion"). In an Equity Conversion, the Payee
  shall receive such number of fully paid and non-assessable shares of the
  Class A Common Stock as is obtained by dividing the Conversion Amount by
  $0.46875 (the "Conversion Price").

       Upon the conversion of all principal and interest hereunder, Payee
  shall have no further rights under this Note except to surrender the
  same for a certificate or certificates representing the securities into
  which this Note shall have automatically converted. As soon as
  practicable thereafter, the Company shall, at its expense, cause to be
  issued in the name of the Payee, a certificate or certificates for the
  number of shares of the securities to which Payee shall be entitled to
  receive (bearing such legends as may be required by applicable
  securities laws). No fractional shares shall be issued on conversion of
  this Note; if any fractional shares would result from such conversion,
  the Company shall pay the cash value thereof to Payee based on the
  Equity Conversion Price.

       1.   Prepayment. The principal amount of this Note may be prepaid
  by the Company in whole or in part, without penalty, at any time, unless
  the Holder elects an Equity Conversion.

       2.   Covenants of Company. The Company covenants and agrees that,
  so long as this Note shall be outstanding, it will:

            (a)  Do or cause to be done all things reasonably necessary to
  preserve and keep in full force and effect its corporate existence,
  rights and franchises and comply with all laws applicable to the
  Company, except where the failure. to comply would not have a material
  adverse effect on the Company.

            (b)  At all times reasonably maintain, preserve, protect and
  keep its property used or useful in the conduct of its business in good
  repair, working order and condition, excluding normal wear and tear and
  Act of God, and from time to time make all needful and proper repairs,
  renewals, replacements, betterments and improvements thereto as shall be
  reasonably required in the conduct of its business.

            (c)  To the extent necessary for the operation of its
  business, keep adequately insured by all financially sound reputable
  insurers, all property of a character usually insured by similar
  corporations and carry such other insurance as is usually carried by
  similar corporations.

            (d)  At all times keep true and correct books, records and
  accounts.

       3.   Events of Default.

            (a)  If one or more of the events listed in this Section 3,
  herein called events of default, shall happen and be continuing, the
  holder of this Note may send a Notice of Default to Company. Company
  shall have thirty (30) days from the date of receipt of the Notice of
  Default to cure the default; provided however, if an event of default
  was caused by an Act of God, Company shall have sixty (60) days from the
  date of receipt of the Notice of Default to cure the default (the "Cure
  Period"). If Company fails to -completely cure the default during the
  Cure Period, this Note shall become and be due and payable upon written
  demand made by the holder hereof.

                 (1)  Default in the payment of the principal and accrued
  interest on this Note or any of the Notes issued pursuant to 5(a) hereof
  when and as the same shall become due and payable, whether by
  acceleration or otherwise.

                 (2)  Application for, or consent to, the appointment of a
  receiver, trustee, or liquidator of the Company or of its property.

                 (3)  General assignment by the Company for the benefit of
  creditors.

                 (4)  Filing by the Company of a voluntary petition in
  bankruptcy or a petition or an answer seeking reorganization, or an
  arrangement with creditors or the failure by the Company generally to
  pay debts, as they become due.

                 (5)  Entering against the Company of a court order
  approving a petition filed against it under the Federal bankruptcy laws,
  which order shall not have been vacated or set aside or otherwise
  terminated within sixty (60) days.

                 (6)  Any representation or warranty of the Company
  contained in the Subscription Agreement, Security Agreement, Form UCC-1
  related to the obligations hereunder, Patent Mortgage related to the
  obligations hereunder or any related documents (collectively, the "Loan
  Documents") is false or misleading in any material respect on the date
  made.

                 (7)  Default by the Company in any obligation under the
  Loan Documents the effect of which is reasonably likely to reduce the
  Company's ability to repay principal or interest under the Note when
  due.

                 (8)  The Company voluntarily or involuntarily dissolves
  or is dissolved.

                 (9)  The Company is enjoined, restrained, or in any way
  prevented by the order of any court or any administrative or regulatory
  agency from conducting all or any material part of its business affairs
  the effect of which is reasonably likely to reduce the Company's ability
  to repay principal or interest under the Note when due.

                 (10) The violation by the Company of any material order,
  regulation, writ, injunction, or decrees of any government, governmental
  instrumentality or court, domestic or foreign, the effect of which is
  reasonably likely to reduce the Company's ability to repay principal or
  interest under the Note when due.

            (b)  The Company agrees that notice of the occurrence of any
  of event of default will be promptly given to the holder at his or her
  registered address by certified mail.

            (c)  In case any one or more of the events of default
  specified above shall happen and be continuing, the holder of this. Note
  may proceed to protect and enforce his rights by suit in the specific
  performance of any covenant or agreement contained in this Note or in
  aid of the exercise of any power granted in this Note or may proceed to
  enforce the payment of this Note or to enforce any other legal or
  equitable rights as such holder.

       4.   Amendments. This Note may only be amended with the written
  consent of the holder.

       5.   Miscellaneous.

            (a)  This Note has been issued by the Company pursuant to
  authorization of the Board of Directors of the Company.

            (b)  The Company may consider and treat the person in whose
  name this Note shall be registered as the absolute owner thereof for all
  purposes whatsoever (whether or not this Note shall be overdue) and the
  Company shall not be affected by any notice to the contrary. The
  registered owner of this Note shall have the right to transfer it by
  assignment (subject to the limitations on transfer contained in the
  Subscription Agreement) and the transferee thereof shall upon his
  registration as owner of this Note, become vested with all the powers
  and rights of the transferor. Registration of any new owner shall take
  place upon presentation of this Note to the Company at its offices,
  30689 Huntwood Avenue, Hayward, California 94544, together with a duly
  authenticated assignment. In case of transfer by operation of law, the
  transferee agrees to notify the Company of such transfer and of his
  address and to submit appropriate evidence regarding the transfer so
  that this Note may be registered in the name of the transferee. This
  Note is transferable only on the books of the Company by the holder
  hereof, in person or by attorney, on the surrender hereof, duly
  endorsed. Communications sent to any registered owner shall be effective
  as against all holders or transferees of the Note not registered at the
  time of sending the Communication.

            (c)  Payments of interest shall be made as specified above to
  the registered owner of this Note. Payment of principal and interest
  shall be made to the registered owner of this Note upon presentation of
  this Note upon or after maturity.

            (d)  This Note shall be construed and enforced in accordance
  with the laws of the State of California.

  IN WITNESS WHEREOF the Company has caused this Note to be signed in its
  name by its President.

  SEPRAGEN CORPORATION

  By: /s/ Vinit Saxena
  Title: President

                              EXHIBIT 10.10

                             SECURITY AGREEMENT

       This SECURITY AGREEMENT is made as of the 18th day of August, 1998
  by SEPRAGEN CORPORATION., a California corporation, with its principal
  place of business at 30689 Huntwood Avenue, Hayward, California 94544
  ("Debtor"), in favor of K. CHARLES JANAC, with an address at 651 River
  Oaks Parkway, San Jose, CA 95134, c/o Smart Machines (the "Secured
  Party").

       1.   DEFINITIONS.

       As used in this Agreement,

       "Agreement" means this Security Agreement, as it may be amended,
  modified or supplemented from time to time.

       "Business Day" means a day other than Saturday or Sunday on which
  banks are open for business in California.

       "Collateral" means all personal property and interests in personal
  property now owned or hereafter acquired by Debtor in or upon which a
  security interest, lien or mortgage has been, or is now or hereafter,
  granted to Secured Party, whether under this Agreement or under any of
  the other Loan Documents.

       "Default" means the occurrence or existence of any of the events
  listed in Section 4 of this Agreement.

       "Lien" means any mortgage, pledge, lien, hypothecation, security
  interest or other charge, encumbrance or preferential arrangement,
  including, without limitation, the retained security title of a
  conditional vendor or lessor.

       "Loan Documents" means, collectively, this Agreement; the Note; the
  Subscription Agreement between Debtor and Secured Party (the
  "Subscription Agreement"); the Patent Mortgage; and Form UCC-1, each
  executed of even date herewith, and all other agreements, instruments
  and documents now or hereafter executed and/or delivered by Debtor to
  the Secured Party, in order to evidence or secure the Obligations, as
  each may be amended, modified or supplemented from time to time.

       "Note" means the Convertible Promissory Note, dated as of August
  18, 1998, executed by Debtor as may be amended, modified or supplemented
  or modified from time to time.

       "Obligations" means all of Debtor s liabilities, obligations and
  indebtedness to the Secured Party of any and every kind and nature,
  whether heretofore, now or hereafter owing, arising, due or payable and
  howsoever evidenced, created, incurred, acquired, or owing, whether
  primary, secondary, direct, contingent, fixed or otherwise (including,
  without limitation, obligations of performance) and whether arising or
  existing under written agreement, oral agreement or by operation of law,
  including, without limitation, all Debtor s indebtedness and obligations
  to the Secured Party under (i) the Subscription Agreement; (ii) the
  Note; (iii) the other Loan Documents. The term includes, without
  limitation, all interest, charges, expenses, fees, reasonable attorneys 
  fees and disbursements and any other sum chargeable under this
  Agreement, the Note, and the other Loan Documents.

       The foregoing definitions shall be equally applicable to both the
  singular and plural forms of the defined terms. Terms used in this
  Agreement and not defined herein or in the Note shall have the meanings
  given such terms in the Code, as defined in Section 2.1 below.
<PAGE>
       2.   SECURITY INTEREST.

       2.1  Grant of Security Interest. To secure payment and performance
  of the Obligations, Debtor hereby grants to the Secured Party a right of
  setoff against and a continuing security interest in and to all of
  Debtor s now existing or owned and hereafter arising or acquired: (a)
  all accounts (including, without limitation, all accounts receivable),
  chattel paper, claims, contract rights, leases and rental income
  thereunder, leasehold interests, letters of credit, instruments and
  documents ("Accounts"), and all goods sold, leased or otherwise disposed
  of by Debtor which have given rise to Accounts and which have been
  returned to or repossessed or stopped in transit by Debtor; (b) all
  patents, copyrights and trademarks, and all applications for and
  registrations of the foregoing, all franchise rights, trade names,
  goodwill, beneficial interests, rights to tax refunds and all other
  general intangibles of any kind or nature whatsoever ("General
  Intangibles"); (c) all inventory and goods of the Debtor, wherever
  located, whether in transit, held by others for the Debtor s account,
  covered by warehouse receipts, purchase orders or contracts, or in the
  possession of any carriers, forwarding agents, truckers, warehousemen,
  vendors or other persons, including, without limitation, all raw
  materials, work-in-process, finished merchandise, supplies, goods,
  incidentals, office supplies, packaging materials and all materials used
  or consumed in Debtor s business ("Inventory"); (d) goods (other than
  Inventory), including all returned, reconsigned and repossessed goods,
  machinery, equipment, vehicles, appliances, furniture, furnishings and
  fixtures ("Equipment"); (e) monies, reserves, deposits, certificates of
  deposit and deposit accounts and interest or dividends thereon,
  guaranties, securities, cash, cash equivalents and other property
  whether or not in the possession or under the control of, Secured Party
  or their respective bailee; (f) all books, records, computer records,
  ledger cards, programs and other computer materials, customer and
  supplier lists, invoices, orders and other property and general
  intangibles at any time evidencing or relating to the contents thereof
  ("Records"); (g) all accessions to any of the foregoing and all
  substitutions, renewals, improvements and replacements of and additions
  thereto; (h) all other property of Debtor, real and personal; and (i)
  all products and proceeds of the foregoing (whether such proceeds are in
  the form of cash, cash equivalents, proceeds of insurance policies,
  Accounts, General Intangibles, Inventory, Equipment, Records or
  otherwise). Debtor further assigns to Secured Party the Debtor s right
  of stoppage in transit and Debtor s right to reclaim goods from
  customers and Account Debtors (as hereinafter defined) under Section 2-
  702 of the Illinois Uniform Commercial Code, as amended (the "Code").
  Debtor and the Secured Party hereby acknowledge their mutual intention
  that the security interest granted herein will attach to Collateral when
  Debtor executes and delivers this Agreement or, in the case of any
  Collateral acquired by Debtor after the execution and delivery hereof,
  upon Debtor first acquiring rights therein. Debtor hereby acknowledges
  and agrees, subject hereto, that Debtor has rights in the Collateral and
  that value has been given.

       2.2  Preservation of Collateral and Perfection of Security
  Interests Therein. Until all of the Obligations of Debtor shall have
  been indefeasibly paid and satisfied in cash, the Secured Party shall be
  entitled to retain its security interests in and to all existing
  Collateral, and all proceeds and products thereof. Debtor agrees that it
  shall execute and deliver to the Secured Party, concurrently with the
  execution of this Agreement, and at any time or times hereafter at the
  request of the Secured Party, all financing statements or other
  documents (and pay the cost of filing or recording the same in all
  public offices deemed necessary by the Secured Party) as Secured Party
  may request, in a form satisfactory to Secured Party, to perfect and
<PAGE>
  keep perfected the security interests in the Collateral or to otherwise
  protect and preserve the Collateral and Secured Party s security
  interests therein. Should Debtor fail to do so, Secured Party is
  authorized to sign any such financing statements as Debtor s agent.
  Debtor further agrees that a carbon, photographic, photostatic or other
  reproduction of this Agreement or of a financing statement is sufficient
  as a financing statement. Notwithstanding anything herein to the
  contrary, Debtor may sell or license collateral in the ordinary course
  of business.

       2.3  Loss of Value of Collateral. Debtor agrees to notify Secured
  Party promptly of any material loss or depreciation in the value of the
  Collateral, other than loss or depreciation occurring in the ordinary
  course of Debtor s business.

       3.   REPRESENTATIONS, WARRANTIES AND COVENANTS.

       3.1  Recordkeeping. Debtor covenants with Secured Party that Debtor
  shall at all times hereafter keep accurate and complete records of its
  finances, in accordance with sound accounting practices and generally
  accepted accounting principles, all of which records shall be available
  for inspection during Debtor s usual business hours at the request of
  Secured Party.

       3.2  Asset Warranties. Debtor represents and warrants to Secured
  Party that the Collateral is located at the premises of Debtor as
  provided for in the first paragraph hereof is not in transit. None of
  the Collateral will be removed from such locations without prior written
  notice to Secured Party, except for use or sale in the ordinary course
  of business. Except for the security interest held by Pitney Bowes
  Credit Corporation ("Pitney Bowes"), the Collateral is not subject to
  any lien, encumbrance, mortgage or security interest whatsoever except
  for the security interests granted to Secured Party. Debtor shall not
  permit any lien, encumbrance, mortgage or security interest whatsoever
  to attach to any of the Collateral, except in favor of Secured Party.

       3.3  Verification of Accounts. After the occurrence of a Default
  hereunder, Secured Party shall have the right, at any time or times
  hereafter, in Secured Party s or in Debtor s name, to verify the
  validity, amount or any other matter relating to any Accounts, by mail,
  telephone, telegraph or otherwise.

       3.4  Appointment of Secured Party as Debtor s Attorney-in-Fact.
  Debtor hereby irrevocably designates, makes, constitutes and appoints
  Secured Party (and all persons designated by Secured Party in writing to
  Debtor) as Debtor s true and lawful attorney-in-fact, and authorizes
  Secured Party, in Debtor s or Secured Party s name, to do the following:
  at any time after the occurrence of a Default, (i) demand payment of
  Accounts of Debtor; (ii) enforce payment of accounts of Debtor by legal
  proceedings or otherwise; (iii) exercise all of Debtor s rights and
  remedies with respect to proceedings brought to collect any Account;
  (iv) sell or assign any Account of Debtor upon such terms, for such
  amount and at such time or times as Secured Party deems advisable; (v)
  settle, adjust, compromise, extend or renew any Account of Debtor; (vi)
  discharge and release any Account of Debtor; (vii) prepare, file and
  sign Debtor s name on any proof of claim in bankruptcy or other similar
  document against any Account Debtor; (viii) have access to any postal
  box of Debtor and notify the post office authorities to change the
  address for delivery of Debtor s mail to an address designated by
  Secured Party; and (ix) do all other acts and things which are
  necessary, in Secured Party s discretion, to fulfill Debtor s
  Obligations under this Agreement. Secured Party shall not exercise its
  rights arising as a result hereof until after the occurrence of a
<PAGE>
  Default hereunder.

       3.5  Notice to Account Debtors. Following the occurrence of a
  Default under this Agreement, Secured Party may, in its sole discretion,
  at any time or times, without prior notice to Debtor, notify any or all
  Account Debtors that the Accounts of Debtor have been assigned to
  Secured Party, that Secured Party has a security interest therein, and
  that all payments upon such Accounts be made directly to Secured Party
  or as otherwise specified by Secured Party.

       3.6  Safekeeping of Assets and Asset Covenants. Secured Party shall
  not be responsible for: (a) the safekeeping of the Collateral; (b) any
  loss or damage to all or any part of the Collateral; (c) any diminution
  in the value of all or any part of the Collateral; or (d) any act or
  default of any carrier, warehouseman processor, bailee, forwarding
  agency or any other person with respect to all or any part of the
  Collateral. All risk of loss, damage, destruction or diminution in value
  of all or any part of the Collateral of Debtor shall be borne by Debtor.

       3.7  Insurance. Debtor shall insure the Collateral at all times
  against all hazards specified by Secured Party, including, without
  limitation, fire, theft and risks covered by extended coverage
  insurance, and such policies shall be payable to Secured Party as its
  interest may appear. Such policies of insurance shall be satisfactory to
  Secured Party as to form, amount and insurer. Debtor shall furnish
  certificates, policies or endorsements to Secured Party as proof of such
  insurance, and if Debtor fails to do so, Secured Party is authorized but
  not required to obtain such insurance at Debtor s expense. All policies
  shall provide for at least thirty (30) days prior written notice to
  Secured Party of cancellation or non-renewal. Secured Party may act as
  attorney-in-fact for Debtor in making, adjusting and settling any claims
  under any such insurance policies. Debtor hereby assigns to Secured
  Party all of its right, title and interest to any insurance policies
  insuring the Collateral, including, without limitation, all rights to
  receive the proceeds of insurance, and directs all insurers to pay all
  such proceeds directly to Secured Party and authorizes Secured Party to
  endorse Debtor s name on any instrument for such payment.

       3.8  Transfer of Collateral. Debtor shall not sell, lease,
  transfer, assign or otherwise dispose of any of the Collateral or any
  interest therein without the prior written consent of Secured Party in
  each instance, except Inventory sold to buyers in the ordinary course of
  business.

       3.9  Damage to Collateral. Debtor shall immediately notify Secured
  Party in writing of any destruction of, or any substantial damage to,
  any of the Collateral.

       3.10 Change of Place of Business. Debtor shall immediately notify
  Janac in writing of any change in any of its place of business or the
  opening of any new place of business.

       3.11 Inspection. With reasonable prior notice, Debtor shall at all
  times during normal business hours allow Secured Party or its agents to
  examine and inspect the Collateral wherever located as well as Debtor s
  books and records, and to make extracts and copies of them, it being
  understood that Secured Party shall use reasonable efforts in the normal
  course of its operations to keep confidential all such information that
  (a) is not in the public domain, and (b) is not required to be disclosed
  by any court, agency or authority of competent jurisdiction, provided,
  however, that the requirement to keep such information confidential
  shall not apply to the extent necessary in order for Secured Party to
  foreclose on or otherwise deal with the Collateral in the Secured
<PAGE>
  Party s best interests upon the occurrence of a Default.

       3.12 Mergers, Etc. Debtor shall not become a party to any
  consolidation, merger, liquidation or dissolution or organize, purchase,
  assume or acquire any subsidiary or joint venture or partnership
  interest or interest in any other business entity, without the prior
  written consent of Secured Party.

       3.13 Change of Name. Debtor shall notify Secured Party of any
  intended change of Debtor s name, and will notify Secured Party when
  such change becomes effective.

       3.14 Organization. Debtor is a corporation duly organized, validly
  existing and in good standing under the laws of the State of California.
  Debtor is duly qualified and in good standing in each state in which the
  failure to so qualify would have a material adverse effect on its
  business.

       3.15 Authority. Debtor has full corporate right and power to enter
  into and perform its obligations under this Agreement and the other Loan
  Documents to which Debtor is a party. The execution, delivery and
  performance of this Agreement and the other Loan Documents to which
  Debtor is a party have been duly authorized by all necessary corporate
  action of Debtor, and this Agreement and the other Loan Documents to
  which Debtor is a party constitute valid and binding obligations of
  Debtor enforceable against Debtor in accordance with their respective
  terms, subject to applicable bankruptcy, reorganization, insolvency or
  similar laws affecting the enforcement of creditor s rights generally.

       3.16 No Conflicts. The execution, delivery and performance by
  Debtor of this Agreement and each of the other Loan Documents do not and
  shall not:

  (a) contravene or constitute a default (or an event that, with due
  notice or the lapse of time, or both, would constitute a default) under
  or result in any breach of, or cause or permit the acceleration of the
  maturity of any debt or obligation pursuant to, Debtor s Articles of
  Incorporation or any document, commitment or other agreement to which
  Debtor is a party or by which any of Debtor s property is bound; or (b)
  violate any statute or law or any judgment, decree, order, regulation or
  rule of any court or governmental authority applicable to Debtor.

       3.17 Actions or Proceedings. There are no actions or proceedings
  which are pending or threatened against Debtor which might result in any
  material and adverse change in its financial condition or materially
  affect the Collateral pledged hereunder.

       3.18 Violation of Law. Debtor is not in violation of any applicable
  federal, state, municipal or county statue, regulation or ordinance
  which may materially and adversely affect its business, property,
  assets, operations or conditions, financial or otherwise. Except with
  respect to certain employment taxes and FICA obligations, Debtor agrees
  that, so long as any Obligations shall remain unpaid or outstanding,
  Debtor shall comply with all applicable laws, rules, regulations, and
  orders, such compliance to include, without limitation, paying before
  the same become delinquent all taxes~ assessments, and governmental
  charges imposed upon Debtor or upon Debtor s property.

       3.19 Consents. All authorizations, consents, approvals,
  registrations, exemptions and licenses required to be obtained by Debtor
  or which are necessary for the borrowing contemplated by the Note and
  the other Loan Documents and the execution and delivery by Debtor of the
  Note and the Loan Documents to which Debtor is a party, and the
<PAGE>
  performance by Debtor of each of Debtor s obligations hereunder and
  thereunder, if any, have been obtained and are in full force and effect.

       3.20 Use of Proceeds. Debtor will use the proceeds of the Note for
  purposes specified in the Subscription Agreement.

       3.21 Accuracy of Information. All factual information heretofore or
  contemporaneously furnished by or on behalf of Debtor to Secured Party
  for purposes of or in connection with the Note or any transaction
  contemplated hereby is, and all other factual information hereafter
  furnished by or on behalf of Debtor to Secured Party will be, true and
  accurate in every material respect on the date as of which such
  information is dated or certified, and Debtor has not omitted and will
  not omit any material fact necessary to prevent such information from
  being false or misleading. Debtor has disclosed to Secured Party in
  writing all facts which might materially and adversely affect the
  credit, financial condition, affairs or prospects of Debtor, or Debtor s
  ability to perform Debtor s obligations under the Note.

       3.22 Liens. Debtor shall not, without the prior written consent of
  Secured Party, create, incur, assume or suffer to exist any lien,
  security interest, encumbrance or other claim of any nature whatsoever
  on any of its assets, including, without limitation, the Collateral,
  other than the security interest granted in favor of Secured Party or
  Pitney Bowes.

       4.   DEFAULTS: RIGHTS AND REMEDIES OF SECURED PARTY.

       4.1  Defaults. Each of the following occurrences shall constitute a
  "Default" under this Agreement:

       (a)  Debtor s failure to pay when due any of the payment
  obligations under this Agreement or under the Note.

       (b)  The occurrence of any material default by Debtor, or Debtor s
  failure or neglect to perform, keep or observe any of the covenants,
  conditions, promises or agreements contained in one or more of the Loan
  Documents.

       (c)  Any representation or warranty made or deemed made by Debtor
  to Secured Party herein or in any of the other Loan Documents or in any
  written statement or certificate at any time given pursuant to any of
  the Loan Documents is false or misleading in any material respect on the
  date made.

       (d)  A judgment or order is rendered against Debtor the effect of
  which is reasonably likely to reduce the Company ~s ability to repay
  principal or interest under the Note when due.

       (e)  A notice of lien, levy, or assessment is filed or recorded
  with respect to all or a material part of the assets of Debtor or the
  Collateral by the United States, or any department, agency or
  instrumentality thereof, or by any state, county, municipality or other
  governmental agency or any taxes or debts owing at any time or times
  hereafter to any one or more of them become a lien upon all or a
  material part of the Collateral the effect of which is reasonably likely
  to reduce the Company s ability to repay principal or interest under the
  Note when due.

       (f)  All or any part of the Collateral in an amount exceeding
  $10,000.00 is attached, seized, subjected to a writ or distress warrant,
  or is levied upon, or comes within the possession of any receiver,
  trustee, custodian or assignee for the benefit of creditors.
<PAGE>
       (g)  A proceeding under any bankruptcy, reorganization, arrangement
  of debt, insolvency, readjustment of debt or receivership law or statute
  is filed against Debtor, which proceeding is either consented to by
  Debtor or not dismissed, vacated or stayed within thirty (30) days after
  the filing thereof, or a proceeding under any bankruptcy,
  reorganization, arrangement of debt, insolvency, readjustment of debt or
  receivership law or statute is filed by Debtor, or Debtor makes an
  assignment for the benefit of creditors, or Debtor takes any corporate
  action to authorize any of the foregoing.

       (h)  Debtor voluntarily or involuntarily dissolves or is dissolved.

       (i)  Debtor is enjoined, restrained, or in any way prevented by the
  order of any court or any administrative or regulatory agency from
  conducting all or any material part of its business affairs the effect
  of which is reasonably likely to reduce the Company s ability to repay
  principal or interest under the Note when due.

       4.2  Rights and Remedies.

       (a)  Rights and Remedies Generally. Upon the occurrence of a
  Default, Secured Party shall issue a Notice of Default to Debtor. Debtor
  shall have thirty (30) days from receipt of such Notice of Default to
  cure the Default; provided however, if an event of default was caused by
  an Act of God, Company shall have sixty (60) days from the date of
  receipt of the Notice of Default to cure the default (the "Cure
  Period"). If Debtor fails to completely cure the Default within the Cure
  Period, all of the Obligations of Debtor shall immediately and
  automatically, without any additional notice of any kind, be immediately
  due and payable in cash. In addition, upon the occurrence of a Default
  and expiration of the Cure Period without a complete cure, Secured Party
  shall have, in addition to any other rights and remedies contained in
  this Agreement, the Note or in any of the other Loan Documents, all of
  the rights and remedies of a secured party under the Uniform Commercial
  Code, as then in effect in California, or other applicable laws, all of
  which rights and remedies shall be cumulative, and non-exclusive, to the
  extent permitted by law. In addition to all such rights and remedies,
  the sale, lease or other disposition of the Collateral, or any part
  thereof, by Secured Party after Default and expiration of the Cure
  Period without a complete cure, may be for cash, credit or any
  combination thereof, and Secured Party may purchase all or any part of
  the Collateral at public or, if permitted by law, private sale, and in
  lieu of actual payment of such purchase price, may set-off the amount of
  such purchase price against the Obligations then owing. Any sales of
  such Collateral may be adjourned from time to time with or without
  notice. Secured Party may, in its sole discretion, cause the Collateral
  to remain on the premises of Debtor, at Debtor s expense, pending sale
  or other disposition of such Collateral. At such times, Secured Party
  shall have the right to repair, process, preserve, protect and maintain
  the Collateral and make such replacements thereof and additions thereto
  as Secured Party may deem advisable. Secured Party shall have the right
  to conduct such sales on the premises of Debtor, at Debtor s expense, or
  elsewhere, on such occasion or occasions as Secured Party may see fit.

       (b)  Entry Upon Premises and Access to Information. Upon the
  occurrence of a Default, Secured Party shall have the right to enter
  upon (to the exclusion of Debtor) the premises of Debtor where the
  Collateral is located (or is believed to be located) without any
  obligation to pay rent to Debtor, or any other place or places where
  such Collateral is believed to be located and kept, and remove such
  Collateral therefrom to the premises of Secured Party or any agent of
  Secured Party, for such time as Secured Party may desire, in order
  effectively to collect or liquidate such Collateral or to retain such
<PAGE>
  Collateral in satisfaction of the Obligations, and/or Secured Party may
  require Debtor to assemble such Collateral and make it available to
  Secured Party at a place or places to be designated by Secured Party.
  Upon the occurrence of a Default, Secured Party shall have the right to
  obtain access to Debtor s data processing equipment, computer hardware
  and software relating to the Collateral and to use all of the foregoing
  and the information contained therein in any manner Secured Party deems
  appropriate; and Secured Party shall have the right to notify post
  office authorities to change the address for delivery of Debtor s mail
  to an address designated by Secured Party and to receive, open and
  process all mail addressed to Debtor.

       (c)  Sale or Other Disposition of Collateral by Secured Party.
  Any notice required to be given by Secured Party of a sale, lease or
  other disposition or other intended action by Secured Party, with
  respect to any of the Collateral, which is deposited in the United
  States mails, postage prepaid and duly addressed to Debtor at the
  address specified below, at least ten (10) days prior to such proposed
  action shall constitute fair and reasonable notice to Debtor of any such
  action. The net proceeds realized by Secured Party upon any such sale or
  other disposition, after deduction for the expense of retaking, holding,
  preparing for sale, selling or the like and the reasonable attorneys 
  and paralegals  fees and legal expenses incurred by Secured Party in
  connection therewith, shall be applied as provided herein toward
  satisfaction of the Obligations. Secured Party shall account to Debtor
  for any surplus realized upon such sale or other disposition, and Debtor
  shall remain liable for any deficiency. The commencement of any action,
  legal or equitable, or the rendering of any judgment or decree for any
  deficiency shall not affect Secured Party s security interest in the
  Collateral until the Obligations are fully paid. Secured Party shall
  have the right to commence, continue or defend proceedings in any court
  of competent jurisdiction in the name of Secured Party, the "Receiver"
  (as hereinafter defined) or Debtor for the purpose of exercising any of
  the rights, powers and remedies set out in this Section 4.2, including,
  without limitation, the institution of proceedings for the appointment
  of a Receiver. Debtor agrees that Secured Party has no obligation to
  preserve rights to the Collateral against any other Person. Secured
  Party is hereby granted a license or other right to use, without charge,
  Debtor s labels, patents, copyrights, rights of use of any name, trade
  secrets, trade names, tradestyles, trademarks, service marks and
  advertising matter, or any property of a similar nature, as it pertains
  to the Collateral, in completing production of, advertising for sale and
  selling any such Collateral, and Debtor s rights under all licenses and
  all franchise agreements shall inure to Secured Party s benefit until
  the Obligations are paid.

       (d)  Appointment of Receiver. Upon the occurrence of a Default,
  Secured Party shall have the right to appoint any Person to be an agent
  or any Person to be a receiver, manager or receiver and manager (the
  "Receiver") of the Collateral and to remove any Receiver so appointed
  and to appoint another if Secured Party so desires; it being agreed that
  any Receiver appointed pursuant to the provisions of this Agreement will
  have all of the powers of Secured Party hereunder, and in addition, will
  have the power to carry on the business of Debtor. The Receiver will be
  deemed to be the agent of Debtor for the purpose of establishing
  liability for the acts or omissions of the Receiver and Secured Party
  will not be liable for such acts or omissions and, without restricting
  the generality of the foregoing, Debtor hereby irrevocably authorizes
  Secured Party to give instructions to the Receiver relating to the
  performance of its duties as set forth herein.

       (e)  Advice of Counsel. Debtor acknowledges that it has been
  advised by its counsel with respect to this transaction and this
<PAGE>
  Agreement, including without limitation any waivers contained herein, or
  has voluntarily chosen not to consult counsel.

       5.   MISCELLANEOUS.

       5.1  Waiver. Secured Party s failure, at any time or times
  hereafter, to require strict performance by Debtor of any provision of
  this Agreement shall not waive, affect or diminish any right of Secured
  Party thereafter to demand strict compliance and performance therewith.
  Any suspension or waiver by Secured Party of a Default under this
  Agreement or a default under any of the other Loan Documents shall not
  suspend, waive or affect any other Default under this Agreement or any
  other default under any of the other Loan Documents, whether the same is
  prior or subsequent thereto and whether of the same or of a different
  kind or character. None of the undertakings, agreements, warranties,
  covenants and representations of Debtor contained in this Agreement or
  any of the other Loan Documents, and no Default under this Agreement or
  default under any of the other Loan Documents, shall be deemed to have
  been suspended or waived by Secured Party unless such suspension or
  waiver is in writing signed by an officer of Secured Party, and directed
  to Debtor specifying such suspension or waiver.

       5.2  Costs and Attorneys  Fees. If at any time or times hereafter
  Secured Party employs counsel in connection with protecting or
  perfecting Secured Party s security interest in the Collateral or in
  connection with any matters contemplated by or arising out of this
  Agreement, whether (a) to commence, defend, or intervene in any
  litigation or to file a petition, complaint, answer, motion or other
  pleading, (b) to take any other action in or with respect to any suit or
  proceeding (bankruptcy or otherwise), (c) to consult with officers of
  Secured Party to advise Secured Party with respect to this Agreement or
  the other Loan Documents or the Collateral, (d) to protect, collect,
  lease, sell, take possession of, or liquidate any of the Collateral, or
  (e) to attempt to enforce or to enforce any security interest in any of
  the Collateral, to attempt to enforce or to enforce any rights of
  Secured Party to collect any of the Obligations, then in any of such
  events, all of the reasonable attorneys  fees arising from such
  services, and any expenses, costs and charges relating thereto,
  including without limitation all reasonable fees of the paralegals and
  other staff employed by such attorneys, together with interest at the
  rate prescribed in the Note and shall be part of the Obligations,
  payable on demand and secured by the Collateral. Such interest shall
  accrue at the times, and in the manner, provided for in the Note.

       5.3  Expenditures by Secured Party. If Debtor shall fail to pay
  taxes, insurance, assessments, costs or expenses which Debtor is, under
  any of the terms hereof or of any of the other Loan Documents, required
  to pay, or fails to keep the Collateral free from other security
  interests, liens or encumbrances, except as permitted herein, Secured
  Party may, in its sole discretion, after notice to Debtor, make
  expenditures for any or all of such purposes, and the amount so
  expended, together with interest thereon at the rate prescribed in the
  Note and shall be part of the Obligations, payable on demand and secured
  by the Collateral.

       5.4  Custody and Preservation of Collateral. Secured Party shall be
  deemed to have exercised reasonable care in the custody and preservation
  of any of the Collateral in its possession if it takes such action for
  that purpose as Debtor shall request in writing, but failure by Secured
  Party to comply with any such request shall not of itself be deemed a
  failure to exercise reasonable care, and no failure by Secured Party to
  preserve or protect any right with respect to such Collateral against
  prior parties, or to do any act with respect to the preservation of such
<PAGE>
  Collateral not so requested by Debtor, shall of itself be deemed a
  failure to exercise reasonable care in the custody or preservation of
  such Collateral.

       5.5  Assignability; Parties. This Agreement may not be assigned by
  Debtor without the prior written consent of Secured Party. Secured Party
  shall not assign this Agreement without prior written consent of Debtor,
  except for estate planning purposes or through law of decent and
  distribution. Whenever in this Agreement there is reference made to any
  of the parties hereto, such reference shall be deemed to include,
  wherever applicable, a reference to the successors and permitted assigns
  of Debtor and the successors and assigns of Secured Party.

       5.6  Applicable Law of Severability. THIS AGREEMENT SHALL BE
  CONSTRUED IN ALL RESPECTS IN ACCORDANCE WITH, AND GOVERNED BY, THE
  INTERNAL LAWS (AS OPPOSED TO CONFLICT OF LAWS PRINCIPLES) AND DECISIONS
  OF THE STATE OF CALIFORNIA. Whenever possible, each provision of this
  Agreement shall be interpreted in such manner as to be effective and
  valid under applicable law, but if any provision of this Agreement shall
  be prohibited by or invalid under applicable law, such provision shall
  be ineffective only to the extent of such prohibition or invalidity,
  without invalidating the remainder of such provisions or the remaining
  provisions of this Agreement.

       5.7  Application of Payments. Notwithstanding any contrary
  provision contained in this Agreement or in any of the other Loan
  Documents, Debtor irrevocably waives the right to direct the application
  of any and all payments at any time or times hereafter received by
  Secured Party from Debtor or with respect to any of the Collateral, and
  Debtor does hereby irrevocably agree that Secured Party shall have the
  continuing exclusive right to apply and reapply any and all payments
  received at any time or times hereafter, whether with respect to the
  Collateral or otherwise, against the Obligations in such manner as
  Secured Party may deem advisable, notwithstanding any entry by Secured
  Party upon any of its books and records.

       5.8  Marshaling; Payments Set Aside. Secured Party shall be under
  no obligation to marshall any assets in favor of Debtor or any other
  Person or against or in payment of any or all of the Obligations. To the
  extent that Debtor makes a payment or payments to Secured Party or
  Secured Party enforces its security interests or exercises its rights of
  setoff, and such payment or payments or the proceeds of such enforcement
  or setoff or any part thereof are subsequently invalidated, declared to
  be fraudulent or preferential, set aside and/or required to be repaid to
  a trustee, receiver or any other party under any bankruptcy law, state,
  federal or foreign law, common law or equitable cause, then to the
  extent of such recovery, the obligation or part thereof originally
  intended to be satisfied shall be revived and continued in full force
  and effect as if such payment had not been made. or such enforcement or
  setoff had not occurred.

       5.9  Section Titles. The section and subsection titles contained in
  this Agreement shall be without substantive meaning or content of any
  kind whatsoever and are not a part of the agreement between the parties.

       5.10 Continuing Effect. This Agreement, Secured Party s security
  interests in the Collateral of Debtor, and all of the other Loan
  Documents shall continue in full force and effect so long as any
  Obligations of Debtor shall be owed to Secured Party.

       5.11 Notices. Except as otherwise expressly provided herein, any
  notice required or desired to be served, given or delivered hereunder
  shall be in writing, and shall be deemed to have been validly served,
<PAGE>
  given or delivered upon the earlier of (a) personal delivery to the
  address set forth below (b) delivery by facsimile or similar means of
  delivery and (c) in the case of mailed notice, three (3) days after
  deposit in the United States mails, with proper postage for certified
  mail, return receipt requested, prepaid, or in the case of notice by
  Federal Express or other reputable overnight courier service, one (1)
  Business Day after delivery to such courier service, addressed to the
  party to be notified as follows:

       (i)  If to Secured Party at:
                 K. Charles Janac
                 c/o Smart Machines
                 651 River Oaks Parkway
                 San Jose, CA 95134

                 Telephone No.: (408) 324-1234 ext. 104
                 Facsimile No.: (408) 324-1966

       (ii) If to Debtor at:
                 Sepragen Corporation
                 30689 Huntwood Avenue
                 Hayward, CA 94544
                 Attention: President
                 Telephone No:  (5l0)-476-0690
                 Facsimile No:  (510)-476-0655

       or to such other address as each party designates to the other in
       the manner herein prescribed.

       5.12 Equitable Relief. Debtor recognizes that, in the event Debtor
  fails to perform, observe or discharge any of its obligations or
  liabilities under this Agreement, any remedy at law may prove to be
  inadequate relief to Secured Party; therefore, Debtor agrees that
  Secured Party, if Secured Party so requests, shall be entitled to
  temporary and permanent injunctive relief.

       5.13 Entire Agreement. This Agreement, together with the Loan
  Documents executed in connection herewith, constitutes the entire
  Agreement among the parties with respect to the subject matter hereof,
  and supersedes all prior written or oral understandings with respect
  thereto. This Agreement may be amended only by mutual agreement of the
  parties evidenced in writing and signed by the party to be charged
  therewith.

       5.14 Indemnity. Debtor agrees to defend, protect, indemnify and
  hold harmless Secured Party and each and all of its respective officers,
  directors, employees, attorneys and agents ("Indemnified Parties") from
  and against any and all liabilities, obligations, losses, damages,
  penalties, actions, judgments, suits, claims, costs, expenses and
  disbursements of any kind or nature whatsoever (including, without
  limitation, the fees and disbursements of counsel for the Indemnified
  Parties in connection with any investigative, administrative or judicial
  proceeding, whether or not the Indemnified Parties shall be designated
  by a party thereto), which may be imposed on, incurred by, or asserted
  against any Indemnified Party (whether direct, indirect or consequential
  and whether based on any federal, state, local or foreign laws or other
  statutory regulations, including without limitation securities,
  environmental and commercial laws and regulations, under common law or
  at equitable cause, or on contract or otherwise) in any manner relating
  to or arising out of this Agreement or the other Loan Documents, or any
  act, event or transaction related or attendant thereto (including any
  liability under federal, state, local or foreign environmental laws or
  regulations); provided, that Debtor shall not have any obligation to any
<PAGE>
  Indemnified Party hereunder with respect to matters caused by or
  resulting from the willful misconduct or gross negligence of such
  Indemnified Party. To the extent that the undertaking to indemnify, pay
  and hold harmless set forth in the preceding sentence may be
  unenforceable because it is violative of any law or public policy,
  Debtor shall contribute the maximum portion which it is permitted to pay
  and satisfy under applicable law, to the payment and satisfaction of all
  matters incurred by the Indemnified Parties. Any liability, obligation,
  loss, damage, penalty, cost or expense incurred by the Indemnified
  Parties shall be paid to the Indemnified Parties on demand, together
  with interest thereon at the rate prescribed for in the Note from the
  date incurred by the Indemnified Parties until paid by Debtor, be added
  to the Obligations and be secured by the Collateral. The provisions of
  and undertakings and indemnifications set out in this Section 5.14 shall
  survive the satisfaction and payment of the Obligations.

       5.15 Representations and Warranties. Notwithstanding anything to
  the contrary contained herein, each representation or warranty contained
  in this Agreement or any of the other Loan Documents shall survive the
  execution and delivery of this Agreement and the other Loan Documents
  and the repayment of the Obligations.

       5.16 Counterparts. This Agreement may be executed in one or more
  counterparts, each of which shall be deemed an original but all of which
  together shall constitute one and the same instrument.

       5.17 Conflict. To the extent that any provision or term of the
  Subscription Agreement or the Note conflict with any provision or term
  herein, the term or provision of this Agreement shall govern.

       IN WITNESS WHEREOF, this Agreement has been duly executed as of the
  day and year above written.

                                     SEPRAGEN CORPORATION

                                     By: /s/ Vinit Saxena
                                     Its: President

                                     /s/ K. Charles Janac
                                     K. CHARLES JANAC
<PAGE>
                   EXHIBIT A TO UCC-1 FINANCING STATEMENT

  Debtor:                            Secured Party: 
  Sepragen Corporation               K. Charles Janac 
  30689 Huntwood Avenue              c/o Smart Machines Inc.
  Hayward, CA 94544                  651 River Oaks Parkway  
                                     San Jose, CA 95134

       This Financing Statement covers all of Debtor's right, title and
  interest in and to the following types of property, whether currently
  existing or owned or hereafter arising or acquired, wheresoever located
  (collectively, the "Collateral"):

       (a)  accounts (including, without limitation, all accounts
       receivable), chattel paper, claims, contract rights, leases and
       rental income thereunder, leasehold interests, letters of credit,
       instruments and documents ("Accounts"), and all goods sold, leased
       or otherwise disposed of by Debtor which have given rise to
       Accounts and which have been returned to or repossessed or stopped
       in transit by Debtor;

       (b)  all patents, copyrights and trademarks, and all applications
       for and registrations of the foregoing, all franchise rights, trade
       names, goodwill, beneficial interests, rights to tax refunds and
       all other general intangibles of any kind or nature whatsoever
       ("General Intangibles");

       (c)  all inventory and goods of the Debtor, wherever located,
       whether in transit, held by others for the Debtor's account,
       covered by warehouse receipts, purchase orders or contracts, or in
       the possession of any carriers, forwarding agents, truckers,
       warehousemen, vendors or other persons, including, without
       limitation, all raw materials, work-in-process, finished
       merchandise, supplies, goods, incidentals, office supplies,
       packaging materials and all materials used or consumed in Debtor's
       business ("Inventory");

       (d)  goods (other than Inventory), including all returned,
       reconsigned and repossessed goods, machinery, equipment, vehicles,
       appliances, furniture, furnishings and fixtures ("Equipment");

       (e)  monies, reserves, deposits, certificates of deposit and
       deposit accounts and interest or dividends thereon, guaranties,
       securities, cash, cash equivalents and other property whether or
       not in the possession or under -the control of Agent, any Secured
       Party or their respective bailee;

       (f)  all books, records, computer records, ledger cards, programs
       and other computer materials, customer and supplier lists,
       invoices, orders and other property and general intangibles at any
       time evidencing or relating to the contents thereof ("Records");

       (g)  all accessions to any of the foregoing and all substitutions,
       renewals, improvements and replacements of and additions thereto;

       (h)  all other property of Debtor, real and personal; and

       (i)  all products and proceeds of the foregoing (whether such
       proceeds are in the form of cash, cash equivalents, proceeds of
       insurance policies, Accounts, General Intangibles, Inventory,
       Equipment, Records or otherwise).


                               EXHIBIT 10.11

                        PATENT AND TRADEMARK MORTGAGE

       This PATENT, TRADEMARK AND LICENSE MORTGAGE (the "Mortgage") made
  as of this 18th day of August, 1998, by SEPRAGEN CORPORATION a
  California corporation having an address at 30689 Huntwood Avenue,
  Hayward, CA 94544 ("Mortgagor"), in favor of K. CHARLES JANAC
  ("Mortgagee"):

                                 WITNESSETH:

       WHEREAS, Mortgagor and Mortgagee are parties to a certain
  Subscription Agreement (the "Subscription Agreement") and other related
  documents of even date herewith (collectively, with the Subscription
  Agreement, the "Loan Documents"), which Loan Documents provide (i) for
  Mortgagee to extend credit to or for the account of Mortgagor and (ii)
  for the grant by Mortgagor to Mortgagee of a security interest in
  certain of Mortgagor's assets, including, without limitation, its
  patents, patent applications, trademarks, trademark applications, trade
  names, service marks, service mark applications and goodwill;

       NOW, THEREFORE, in consideration of the premises set forth herein
  and for other good and valuable consideration, the receipt, sufficiency
  and adequacy of which are hereby acknowledged, Mortgagor agrees as
  follows:

       1.  Capitalized Terms. All terms capitalized but not otherwise
  defined herein shall have the same meanings herein as in the Loan
  Documents.

       2.  Mortgage of Patents, Trademarks and Licenses. To secure the
  complete and timely satisfaction of all of Mortgagor's Obligations,
  Mortgagor hereby grants, bargains, assigns, mortgages, pledges, sells,
  creates a security interest in, transfers, and conveys to Mortgagee, as
  and by way of a first mortgage and security interest having priority
  over all other security interests, with power of sale, to the extent
  permitted by law, upon the occurrence of an Event of Default, all of
  Mortgagor's right, title and interest in and to all of its now existing:

           (i)    patents and patent applications, including, without
                  limitation, the inventions and improvements described
                  and claimed therein, and those patents listed on Exhibit
                  A attached hereto and hereby made a part hereof, and (a)
                  the reissues, divisions, continuations, renewals,
                  extensions and continuations in-part thereof, (b) all
                  income, damages and payments now and hereafter due or
                  payable under or with respect thereto, including,
                  without limitation, damages and payments for past or
                  future infringements thereof, (c) the right to sue for
                  past, present and future infringements thereof, and (d)
                  all rights corresponding thereto throughout the world
                  (all of the foregoing patents and applications, together
                  with the items described in clauses (a)-(d) of this
                  subsection 2(i), are sometimes hereinafter referred to
                  individually as a "Patent" and, collectively, as the
                  "Patents");

           (ii)   trademarks, trademark registrations, trademark
                  applications, trade names and tradestyles, service
                  marks, service mark registrations and service mark
                  applications, including, without limitation, the
                  trademarks, trade names, service marks and applications
                  and registrations thereof listed on Exhibit B attached
                  hereto and hereby made a part hereof, and (a) renewals
                  or extensions thereof, (b) all income, damages and
                  payments now and hereafter due or payable with respect
                  thereto, including, without limitation, damages and
                  payments for past or future infringements thereof, (c)
                  the right to sue for past, present and future
                  infringements thereof, and (d) all rights corresponding
                  thereto throughout the world (all of the foregoing
                  trademarks, trade names and tradestyles, service marks
                  and applications and registrations thereof, together
                  with the items described in clauses (a)-(d) of this
                  subsection 2(u), are sometimes hereinafter referred
                  individually as a "Trademark", and, collectively, as the
                  "Trademarks"); and

           (iii)  the goodwill of Mortgagor's business connected with and
                  symbolized by the Trademarks.

       3.  Warranties and Representations. Mortgagor warrants and
  represents to Mortgagee that:

           (i)    The Patents and Trademarks have not been adjudged
                  invalid or unenforceable and have not been canceled, in
                  whole or in part and are presently subsisting;

           (ii)   To the best of Mortgagor's knowledge, each of the
                  Patents and Trademarks is valid and enforceable;

           (iii)  Mortgagor is the sole and exclusive owner of the entire
                  and unencumbered right, title and interest in and to
                  each of the Patents and Trademarks, free and clear of
                  any liens, charges and encumbrances, including, without
                  limitation, licenses, shop rights and covenants by
                  Mortgagor not to sue third persons;

           (iv)   Mortgagor has adopted all of the Trademarks;

           (v)    Mortgagor has no notice of any suits or actions
                  commenced or threatened with reference to the Patents or
                  Trademarks; and

           (vi)   Mortgagor has the right to execute and deliver its
                  Mortgage and perform its terms and has entered into or
                  will enter into written agreements with each of its
                  present and future employees, agents and consultants
                  which will enable it to comply with the covenants
                  contained herein.

       4.  Restrictions on Future Agreements. Mortgagor agrees that until
  Mortgagor's Obligations shall have been satisfied in full and the Loan
  Documents shall have been terminated, Mortgagor shall not sell or assign
  its interest in, or grant any license to substantially all of
  Mortgagor's rights under, the Patents or Trademarks, or enter into any
  other agreement with respect to the Patents or Trademarks which is
  inconsistent with Mortgagor's Obligations under this Mortgage, without
  the prior written consent of Mortgagee except in the ordinary course of
  business, and Mortgagor further agrees that it shall not take any
  action, or permit any action to be taken by others subject to its
  control, including, without limitation, licensees, or fail to take any
  action (solely with respect to the Patents and the Tradenames), which
  would affect the validity or enforcement of the rights transferred to
  Mortgagee under this Mortgage. Mortgagee shall cooperate with Mortgagor
  to facilitate third party licenses in the Patents.

       5.  Post-Default Non-exclusive License. If Mortgagor Defaults on
  the Convertible Secured Promissory Note, Mortgagee shall negotiate,, in
  good faith, an arms length transaction pursuant to which Mortgagee may
  grant Mortgagor a non-exclusive license to use the Patents and
  Trademarks listed on Exhibits A and B.

       6.  Royalties; Terms. The term of the mortgages granted herein
  shall extend until the earlier of(i) the expiration of each of the
  respective Patents and Trademarks assigned hereunder, and (ii)
  Mortgagor's Obligations have been paid in full and the Loan Documents
  have been terminated. Upon the occurrence of an Event of Default or
  Default, Mortgagor agrees that the use by Mortgagee of all Patents and
  Trademarks shall be worldwide and without any liability for royalties or
  other related charges from Mortgagee to the Mortgagor.

       7.  Mortgagee's Right to Inspect. Mortgagee shall have the right
  upon prior written notice, after executing a reasonable confidentiality
  agreement and at any time and from time to time during normal business
  hours and prior to payment in full of Mortgagor's Obligations and
  termination of the Loan Documents, to inspect Mortgagor's premises and
  to examine Mortgagor's books, records and operations, including, without
  limitation, Mortgagor's quality control processes.

       8.  Release of Mortgage. This Mortgage is made for collateral
  purposes only. Upon payment in full of Mortgagor's Obligations and
  termination of the Loan Documents, Mortgagee shall execute and deliver
  to Mortgagor all deeds, assignments and other instruments, and shall
  take such other actions, as may be necessary or proper to revest in
  Mortgagor full title to the Patents and Trademarks, subject to any
  disposition thereof which may have been made by Mortgagee pursuant
  hereto or pursuant to the Loan Documents.

       9.  Expenses. All expenses incurred in connection with the
  performance of any of the agreements set forth herein shall be borne by
  Mortgagor. All fees, costs and expenses, of whatever kind or nature,
  including, without limitation, reasonable attorneys  and paralegals 
  fees and legal expenses, incurred by Mortgagee in connection with the
  filing or recording of any documents (including, without limitation, all
  taxes in connection therewith) in public offices, the payment or
  discharge of any taxes, counsel fees, maintenance fees, encumbrances or
  otherwise in protecting, maintaining or preserving the Patents and
  Trademarks, or in defending or prosecuting any actions or proceedings
  arising out of or related to the Patents and Trademarks, shall be borne
  by and paid by Mortgagor on demand by Mortgagee and until so paid shall
  be added to the principal amount of Mortgagor's Obligations and shall
  bear interest at the highest rate provided for in the Note.

       10. Duties of Mortgagor. Mortgagor shall have the duty (i) to
  preserve and maintain all rights in the Patents and Trademarks, and (ii)
  to ensure that the Patents and Trademarks are and remain enforceable.
  Any expenses incurred in connection with Mortgagor's obligations under
  this Section 10 shall be borne by Mortgagor. Mortgagor shall not abandon
  any right to file a patent, trademark or service mark application, or
  abandon any pending patent application, or any other Patent or Trademark
  without the consent of Mortgagee.

       11. Mortgagee's Right to Sue. After the occurrence of an Event of
  Default or Default, Mortgagee shall have the right, but shall in no way
  be obligated, to bring suit in its own name to enforce the Patents and
  Trademarks, and, if Mortgagee shall commence any such suit, Mortgagor
  shall, at the request of Mortgagee, do any and all lawful acts and
  execute any and all proper documents required by Mortgagee in aid of
  such enforcement and Mortgagor shall promptly, upon demand, reimburse
  and indemnify Mortgagee for all reasonable costs and expenses incurred
  by Mortgagee in the exercise of its rights under this Section 11.

       12. Waivers. No course of dealing between Mortgagor and Mortgagee,
  nor any failure to exercise, nor any delay in exercising, on the part of
  Mortgagee, any right, power or privilege hereunder or under the Loan
  Documents shall operate as a waiver thereof; nor shall any single or
  partial exercise of any right, power or privilege hereunder or
  thereunder preclude any other or further exercise thereof or the
  exercise of any other right, power or privilege.

       13. Severability. The provisions of this Mortgage are severable,
  and if any clause or provision shall be held invalid and unenforceable
  in whole or in part in any jurisdiction, then such invalidity or
  unenforceability shall affect only such clause or provision, or part
  thereof, in such jurisdiction, and shall not in any manner affect such
  clause or provision in any other jurisdiction, or any other clause or
  provision of this Mortgage in any jurisdiction.

       14. Modification. This Mortgage cannot be altered, amended or
  modified in any way, except by a writing signed by the parties hereto.

       15. Cumulative Remedies; Power of Attorney; Effect on Subscription
  Agreement. All of Mortgagee's rights and remedies with respect to the
  Patents, Trademarks and Licenses, whether established hereby or by the
  Loan Documents, or by any other agreements or by law shall be cumulative
  and may be exercised singularly or concurrently. Upon the occurrence of
  an Event of Default or Default, Mortgagor hereby authorizes Mortgagee to
  make, constitute and appoint any officer or agent of Mortgagee as
  Mortgagee may select, in its sole discretion, as Mortgagor's true and
  lawful attorney-in-fact, with power to (i) endorse Mortgagor's name on
  all applications, documents, papers and instruments necessary or
  desirable for Mortgagee in the use of the Patents and Trademarks, or
  (ii) take any other actions with respect to the Patents and Trademarks
  as Mortgagee deems to be in the best interest of Mortgagee, or (iii)
  grant or issue any exclusive or non-exclusive license under the Patents
  or Trademarks to anyone, or (iv) assign, pledge, convey or otherwise
  transfer title in or dispose of the Patents or Trademarks to anyone.
  Mortgagee hereby ratifies all that such attorney shall lawfully do or
  cause to be done by virtue hereof. This power of attorney shall be
  irrevocable until Mortgagor's Obligations shall have been paid in full
  and the Security Agreement, including any amendments thereto, has been
  terminated. Mortgagor acknowledges and agrees that this Mortgage is not
  intended to limit or restrict in any way the rights and remedies of
  Mortgagee under the Loan Documents but rather is intended to facilitate
  the exercise of such rights and remedies. Mortgagee shall have, in
  addition to all other rights and remedies given it by the terms of this
  Mortgage and the Loan Documents, all rights and remedies allowed by law
  and the rights and remedies of a secured party under the Uniform
  Commercial Code as enacted in any jurisdiction in which the Patents or
  Trademarks may be located.

       16. Acknowledgment of Mortgagor's Licensing Needs. Mortgagee
  acknowledges that Mortgagor is in the business of licensing the
  Intellectual Property covered by the Patent and Trademark Mortgage. It
  is not the intent of the parties to restrict Mortgagor's ability to
  license the Intellectual Property. Mortgagee will cooperate with
  Mortgagor and not take any action to hinder the execution of licenses
  for the Intellectual Property in Mortgagor's ordinary course of
  business.

       17. Binding Effect; Benefits. This Mortgage shall be binding upon
  the Mortgagor and its respective successors and assigns, and shall inure
  to the benefit of Mortgagee, its successors, nominees and assigns.

       18. Governing Law. This Mortgage shall be governed by and construed
  in accordance with the internal laws of the State of California.

       19. Headings. Paragraph headings used herein are for convenience
  only and shall not modify the provisions which they precede.

       20. Further Assurances. Mortgagor agrees to execute and deliver
  such further agreements, instruments and documents, and to perform such
  further acts, as Mortgagee shall reasonably request from time to time in
  order to carry out the purpose of this Mortgage and agreements set forth
  herein.

       21. Survival of Representations. All representations and warranties
  of Mortgagor contained in this Mortgage shall survive the execution and
  delivery of this Mortgage.





       IN WITNESS WHEREOF, Mortgagor has duly executed this Mortgage in
  favor of Mortgagee as of the date first written above.

                      SEPRAGEN CORPORATION

                      By: /s/ Vinit Saxena
                      Its: President


                      /s/ K. Charles Janac
                      K. CHARLES JANAC





  STATE OF CALIFORNIA )
                      )    ss
  COUNTY OF SAN MATEO )


       The foregoing Patent and Trademark Mortgage was executed and
  acknowledged before me this 18 th day of August, 1998, by Vinit Saxena
  and n/a, personally known to me to be the person and n/a, of Sepragen
  Corporation, a California corporation, on behalf of such corporation.

  Notary Public
  San Mateo County, 

  My Commission expires: 7-3-2001





                               ACKNOWLEDGMENT
  STATE OF CALIFORNIA      )
                           )SS
  COUNTY OF SANTA CLARA    )

  I, Frederick C. Harris, Notary Public in and for and residing in said
  County and State, DO HEREBY CERTIFY that K. Charles Janac personally
  known to me to be the same person whose names is subscribed to the
  foregoing instrument, appeared before me this day in person and
  acknowledged that he signed and delivered said instruments as his own
  free and voluntary act and as the free and voluntary act of said bank
  for the uses and purposes therein set forth.

       GIVEN under my hand and notarial seal this 16 day of August, 1998.

                      /s/Frederick C. Harris
                      Notary Public

                      My Commission Expires: 1-16-02






                       THIS INSTRUMENT PREPARED BY AND
                           AFTER FILING RETURN TO:

                               Kyle Guse, Esq.
                       Heller Ehrman White & McAuliffe
                       2500 Sand Hill Road, Suite 100
                            Menlo Park, CA 94025






                                  EXHIBIT A


                       PATENTS AND PATENT APPLICATIONS

  U.S. PATENTS ISSUED

  1.   Patent Number 4,627,918, issued December 9, 1986, "Chromatography
       Column Using Horizontal Flow", issued to Vinit Saxena and assigned
       to Sepragen Corporation.
                                Sepragen Corporation - File 1723

  2.   Patent Number 4,676,898, issued June 30, 1987, "Electrophoresis -
       Mass Spectrometry Probe", issued to Vinit Saxena and assigned to
       Sepragen Corporation.
                                Sepragen Corporation - File 1724

  3.   Patent Number 4,705,616, issued November 10, 1987, "Chromatography
       Column -Electrophoresis System", issued to Brian D. Andresen and
       Vinit Saxena and assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1731

  4.   Patent Number 4,708,782, issued November 24, 1987, "Chromatography
       Column -Electrophoresis System", issued to Brian D. Andresen and
       Vinit Saxena and assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1725

  5.   Patent Number 4,740,298, issued April 26, 1988, "Chromatography
       Column! Moving Belt Interface", issued to Brian D. Andresen and
       Vinit Saxena and assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1726

  6.   Patent Number 4,833,083, issued May 23, 1989, "Packed Bed
       Bioreactor", issued to Vinit Saxena and assigned to Sepragen
       Corporation.
                                Sepragen Corporation - File 1727

  7.   Patent Number 4,840,730, issued June 20, 1989, "Chromatography
       System Using Horizontal Flow Columns", issued to Vinit Saxena and
       assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1728

  8.   Patent Number 4,865,729, issued September 12, 1989, "Radial Thin
       Layer Chromatography", issued to Vinit Saxena and Brian D. Andresen
       and assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1729

  9.   Patent Number 4,865,947, issued September 19, 1989, "Interface for
       Liquid Chromatography - Mass Spectrometer", issued to Brian D.
       Andresen and Eric R. Fought and assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1932

  10.  Patent Number 5,462,659, issued October 31, 1995, "An Improved
       Chromatography Column", issued to Venit Saxena and Paul Young and
       assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1933

  11.  Euro Patent Number 0530258, issued September 1995, "Absorbent
       Medium", issued to Alan Sanderson, R. Dove, Fang Ming and John
       Howell, and assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1981

  12.  Patent Number 5,492,723, issued February 20, 1996, "Absorbent
       Medium", issued to Alan Sanderson, R. Dove, Fang Ming, and John
       Howell, and assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1740

  13.  Patent Number 5,597,489, issued January 28, 1997, "Method For
       Removing Contaminants From Water", issued to H. Michael Schneider,
       Edward Allen, Richard Woodling, and Roy Barnes and assigned to
       Sepragen Corporation.
                                Sepragen Corporation - File 1739

  14.  Patent Number 5,690,996, issued November 25, 1997, "Cross-Linked
       Cellulose Sponge", issued to Alan Sanderson, Rod Dove, Fang Ming,
       and John Howell and assigned to Sepragen Corporation.
                                Sepragen Corporation - File 1910

  15.  Patent Number 5,756,680, issued May 26, 1998, "Sequential
       Separation of Whey Proteins and Formulation Thereof , issued to
       Salah H. Ahmed, Vinit Saxena, Zahid Mozaffar, and Quirinus R.
       Miranda and assigned to Sepragen Corporation.
                                Sepragen Corporation - File 2338





  U.S. PATENT APPLICATION EXAMINED AND ALLOWED FOR ISSUANCE

  1.   Patent Application, pending for "High Throughput Debittering", has
       been accepted for issuance to Zahid Mozaffar, Quirinus Miranda, and
       Vinit Saxena and assignment to Sepragen Corporation.
                                Sepragen Corporation - File 2397

  2.   Patent Application, pending for "Sequential Separation of Whey",
       has been filed on May 4, 1998, for issuance to Salah H. Ahmed,
       Vinit Saxena, Zahid Mozaffar, and Quirinus R. Miranda and
       assignment to Sepragen Corporation.
                                Sepragen Corporation - File 2181

  FOREIGN PATENTS ISSUED

  1.   U.S. Patent #5,756,680, "Sequential Separation of Whey Proteins and
       Formulations Thereof , has been filed on September 22, 1997 for
       (PCT) foreign patent, in Australia and New Zealand; and (EPC) in
       Switzerland, Ireland and The Netherlands, as of September 22, 1997.
                                Sepragen Corporation - File 2338

  U.S. TRADEMARKS REGISTERED AND PENDING

  1.   Trademark Principal Register, Registration Number 1,419,016,
       registered on December 2, 1986, "SUPERFLO" to Sepragen Corporation.
                                Sepragen Corporation - File 1982

  2.   Trademark Principal Register, Registration Number 1,574,587,
       Registered on January 2, 1990, "QUANTASEP", to Sepragen
       Corporation.
                                Sepragen Corporation - File 1983

  3.   Trademark Principal Register, Registration Number 1,803,149,
  registered on November 9, 1993, "S" Trademark, to Sepragen Corporation.
                                Sepragen Corporation - File 1984

  4.   Trademark applied for "S" and Design. File 01743
  5.   Trademark applied for "Sepragen". File 01742
  6.   Trademark applied for "SepraLac". File 02251
  7.   Trademark applied for "SepraSorb". File 02092

  FOREIGN TRADEMARKS REGISTERED AND PENDING

  1.   "Sepralac" Trademark:

  a.   New Zealand -- International Class 9, Trademark Application #26803
  5, Registration #268035, October 8, 1996.

  b.   Australia -- International Class 9, Registration #03128/1997, July
  25, 1997.

  c.   Denmark -- International Class 9, Registration #03128/1997, July
  25, 1997.

  d.   Switzerland -- International Class 9, Registration #441337, October
  7, 1996.

  e.   Benelux -- International Class 9, Registration #598445, October 4,
  1996.






                                  EXHIBIT B
                                 TRADEMARKS

       The Company's name, helix logo. Superflo and QuantaSep trademarks
  are registered on the Principal Register of Trademarks maintained by the
  U.S. Patent and Trademark Office, and applications to register the mark
  SepraSorb, Sepragen, "S" and Design and Sepralac are pending.

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
LEGEND
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS FOR SEPTEMBER 30, 1998 AS FILED ON FORM 10QSB WITH 
THE SECURITIES AND EXCHANGE COMMISSION AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998             DEC-31-1998
<PERIOD-END>                               SEP-30-1998             SEP-30-1998
<CASH>                                         206,197                 206,197
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  192,799                 192,799
<ALLOWANCES>                                    12,000                  12,000
<INVENTORY>                                    231,355                 231,355
<CURRENT-ASSETS>                               657,860                 657,860
<PP&E>                                         198,157                 198,157
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                                 957,449                 957,449
<CURRENT-LIABILITIES>                        2,033,592               2,033,592
<BONDS>                                              0                       0
                                0                       0
                                    500,000                 500,000
<COMMON>                                    12,913,693              12,913,693
<OTHER-SE>                                (14,489,836)            (14,489,836)
<TOTAL-LIABILITY-AND-EQUITY>                   957,449                 957,449
<SALES>                                        356,395               1,200,199
<TOTAL-REVENUES>                               356,395               1,200,199
<CGS>                                          139,564                 649,391
<TOTAL-COSTS>                                  139,564                 649,391
<OTHER-EXPENSES>                               524,773               1,534,813
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              68,669                 177,951
<INCOME-PRETAX>                              (376,611)             (1,161,956)
<INCOME-TAX>                                 (376,611)             (1,161,956)
<INCOME-CONTINUING>                          (376,611)             (1,161,956)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                 (376,611)             (1,161,956)
<EPS-PRIMARY>                                    (.13)                   (.41)
<EPS-DILUTED>                                    (.13)                   (.41)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission